Ropivacaine

also known as ropivicaine · ropivacaine hydrochloride · Naropin · Ropivacaine HCL · ropivacain · Naropeine · PRF110 · Naropin, 0.5% Injectable Solution · +24 more

Other / unclassified

Developed for: neuropathy, painful · osteoarthritis, knee · osteoarthritis, hip · breast cancer · lumbar disk disease · bone disorder · liver cancer · peripheral nerve lesion
+72 more
· rotator cuff syndrome · appendicitis · brain aneurysm · chronic pain syndrome · delirium · developmental dysplasia of the hip · gallbladder disorder · osteoarthritis · pregnancy disorder · atrial fibrillation · frozen shoulder · heart failure · large intestine disorder · local anesthetic poisoning · migraine disorder · morbid obesity · musculoskeletal system disorder · post-traumatic stress disorder · toe, misshapen · abdominal aortic aneurysm · acute pancreatitis · adolescent idiopathic scoliosis · anal fistula · ankle defects short stature · anterior cutaneous nerve entrapment syndrome · anterior deviation infundibular septum · arthropathy · benign female reproductive system neoplasm · cardiac valvular defect · cerebral palsy · cleft palate · coronary artery disorder · craniofacial and skeletal defects · cryptorchidism · digestive system disorder · disease of bone structure · epidermolysis bullosa · fetal growth restriction · headache disorder · hemorrhoid · hernia, double inguinal · myocardial infarction · neoplasm of testis · nerve compression syndrome · obstetric disorder · ovarian cancer · ovarian cyst · pain agnosia · posterior dislocation of lens · postmenopausal osteoporosis · preeclampsia · respiratory paralysis · scoliosis · soft tissue neoplasm · tenosynovitis of foot and ankle · ulcer of lower limbs · urinary bladder disorder · urinary tract obstruction · urolithiasis · carpal tunnel syndrome · congenital heart malformation · ductal breast carcinoma in situ · impacted teeth, multiple · myofascial pain syndrome · myopathy · paralytic ileus · pectus excavatum · peripheral arterial occlusive disease 1 · rheumatic disorder · temporomandibular joint disorder · thoracic outlet syndrome · uterine corpus leiomyoma
Investigated by: University of California, San Diego · Yonsei University · Beijing Tiantan Hospital · Duke University · Centre Hospitalier Universitaire, Amiens · Chuncheon Sacred Heart Hospital
+409 more
· London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · Nordsjaellands Hospital · Nîmes University Hospital · University Hospital, Clermont-Ferrand · University of California, San Francisco · University of Florida · Zealand University Hospital · Assistance Publique - Hôpitaux de Paris · China Medical University, China · McGill University Health Centre/Research Institute of the McGill University Health Centre · McMaster University · Northwestern University · PainReform LTD · San Gerardo Hospital · Seoul National University Hospital · Thomas Jefferson University · United States Department of Defense · University Hospital, Rouen · University Hospital, Strasbourg, France · University of Minnesota · Virginia Commonwealth University · Ajou University School of Medicine · Asan Medical Center · AstraZeneca · Boston Children's Hospital · Cali Pharmaceuticals LLC · Centre Hospitalier Universitaire Dijon · Centre Hospitalier Universitaire Vaudois · Columbia University · Cui Xulei · Fondazione IRCCS Policlinico San Matteo di Pavia · Guangzhou General Hospital of Guangzhou Military Command · Huazhong University of Science and Technology · Institut Curie · KK Women's and Children's Hospital · Massachusetts General Hospital · Mayo Clinic · Montefiore Medical Center · Peking Union Medical College Hospital · Poznan University of Medical Sciences · St. Joseph's Healthcare Hamilton · University Hospital, Angers · University Hospital, Bordeaux · University Hospital, Geneva · University Hospital, Lille · University of California, Los Angeles · University of Saskatchewan · University of Texas Southwestern Medical Center · Vinmec Healthcare System · Örebro University, Sweden · Baxter Healthcare Corporation · CMC Ambroise Paré · Carmel Medical Center · Centre Hospitalier Departemental Vendee · Daniel Hägi-Pedersen · Ewha Womans University Mokdong Hospital · Fondation Apicil · Fujian Provincial Hospital · General Hospital of Ningxia Medical University · Healthpoint Hospital · Hospices Civils de Lyon · Innovation Fund Denmark · Johns Hopkins University · Keimyung University Dongsan Medical Center · Lundbeck Foundation · Medical University of Silesia · Milton S. Hershey Medical Center · Naestved Hospital · Nanjing First Hospital, Nanjing Medical University · Nantes University Hospital · Ochsner Health System · Ottawa Hospital Research Institute · PHARMAFINA · Peking University First Hospital · all 415 on the full record

Regulatory milestones approvals, filings & regulatory actions · 2 recorded

Milestone	Jurisdiction	Brand	Indication	Date	Sentence it was read from
Label expansion	US (FDA)	NAROPIN	—	2000-11-02	fda.gov ↗
Approved	US (FDA)	NAROPIN	—	1996-09-24	fda.gov ↗

Trials 493 · started per year

today

US approved 1996

199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 010 trials
Phase 0	NCT06570538	Sep 2024 → May 2025 overdue	—	Affiliated Cancer Hospital & Institute of Guangzhou Medical University	Not yet recruiting	No outcome recorded
Phase 0	NCT05824338	Aug 2024 → Jul 2025 overdue	—	Fraser Health	Recruiting	No outcome recorded
Phase 0	NCT06720285	Oct → Nov 2023	—	Universitas Airlangga	Completed	No outcome recorded
Phase 0	NCT05247255	Mar 2022 → Dec 2026 expected	—	University of California, Los Angeles	Enrolling by invitation	No outcome recorded
Phase 0	NCT03817034	Mar 2021	—	Massachusetts General Hospital	Withdrawn	No outcome recorded
Phase 0	NCT04759742	Mar 2021 → Jun 2023	—	Yanchao Yang	Completed	No outcome recorded
Phase 0	NCT04302181	Oct 2020 → Jul 2021	post-traumatic stress disorder	The University of Texas Health Science Center at San Antonio	Completed	No outcome recorded
Phase 0	NCT03906838	Jan → Nov 2020	head and neck neoplasm, substance-related disorder	University of Florida	Withdrawn	No outcome recorded
Phase 0	NCT02361775	Jul 2012 → Oct 2014	—	University of Minnesota	Completed	No outcome recorded
Phase 0	NCT01355757	Jun 2011 → Jan 2013	rotator cuff syndrome	St. Luke's-Roosevelt Hospital Center	Completed	No outcome recorded
Phase 111 trials
Phase 1	NCT06925789	Jul 2025 → May 2026	—	Milton S. Hershey Medical Center	Withdrawn	No outcome recorded
Phase 1	NCT06781632	Nov 2024 → Feb 2025	—	PHARMAFINA	Completed	No outcome recorded
Phase 1	NCT06095973	Oct 2023 → Sep 2024	neuropathy, painful	G2GBio, Inc.	Completed	No outcome recorded
Phase 1	NCT05343299	May 2022 → Jun 2023	—	Nîmes University Hospital	Completed	No outcome recorded
Phase 1	NCT05442411	Mar 2021 → Mar 2022	—	Universiti Sains Malaysia	Completed	No outcome recorded
Phase 1	NCT03805360	May 2019 → Jan 2020	—	Virginia Commonwealth University	Terminated	No outcome recorded
Phase 1	NCT02801799	Oct → Nov 2016	neuropathy, painful	Nordsjaellands Hospital	Terminated	No outcome recorded
Phase 1	NCT02297191	Jul → Nov 2014	—	Medical University of South Carolina	Completed	No outcome recorded
Phase 1	NCT02139982	Jan 2011 → Dec 2012	—	Wenzhou Medical University	Completed	No outcome recorded
Phase 1	NCT00722709	Sep 2008 → Nov 2009	—	University of Auckland, New Zealand	Completed	No outcome recorded
Phase 1	NCT01307969	Feb → May 2007	local anesthetic poisoning	University of Campinas, Brazil	Completed	No outcome recorded

Phase 1/26 trials
Phase 1/2	NCT06447194	Oct 2025 → Jan 2027	intervertebral disk degenerative disorder, lumbar spinal stenosis, spondylolisthesis	University of Maryland, Baltimore	Withdrawn	No outcome recorded
Phase 1/2	NCT02624089	Jan 2016 → Jun 2017	appendicitis	McGill University Health Centre/Research Institute of the McGill University Health Centre	Unknown	No outcome recorded
Phase 1/2	NCT01866917	Apr 2013 → Apr 2016	—	Montefiore Medical Center	Terminated	No outcome recorded
Phase 1/2	NCT04051684	Apr → May 2013	—	Montefiore Medical Center	Completed	No outcome recorded
Phase 1/2	NCT00883194	Oct 2010 → Apr 2011	—	PainReform LTD	Completed	No outcome recorded
Phase 1/2	NCT00910013	Apr 2006 → Mar 2008	—	Hopital de l'Enfant-Jesus	Completed	No outcome recorded
Phase 239 trials
Phase 2	NCT05953766	Sep 2025 → Jul 2026 overdue	—	Mount Sinai Hospital, Canada	Recruiting	No outcome recorded
Phase 2	NCT07131657	Sep → Dec 2025	—	PHARMAFINA	Completed	No outcome recorded
Phase 2	NCT06574269	Sep 2024 → Jul 2026 overdue	—	TLC Biopharmaceuticals, Inc.	Recruiting	No outcome recorded
Phase 2	NCT05889741	Feb 2024 → Mar 2027 expected	post-traumatic stress disorder	The University of Texas Health Science Center at San Antonio	Recruiting	No outcome recorded
Phase 2	NCT06008795	Dec 2023 → Jan 2027 expected	acquired aneurysmal subarachnoid hemorrhage, headache disorder	University of Florida	Recruiting	No outcome recorded
Phase 2	NCT05625802	Feb 2023 → Jan 2024	urinary tract obstruction, urolithiasis	University of Michigan	Completed	No outcome recorded
Phase 2	NCT05561309	Oct 2022 → Dec 2024	—	Shanghai Hengrui Pharmaceutical Co., Ltd.	Unknown	No outcome recorded
Phase 2	NCT05411861	Jun → Sep 2022	—	Cali Pharmaceuticals LLC	Completed	No outcome recorded
Phase 2	NCT05216055	Apr → Dec 2022	large intestine disorder	University of Colorado, Denver	Withdrawn	No outcome recorded
Phase 2	NCT05160298	Oct 2021 → Nov 2022	—	University Hospital, Clermont-Ferrand	Completed	No outcome recorded
Phase 2	NCT05080959	Jul → Dec 2021	hernia, double inguinal	Cali Pharmaceuticals LLC	Completed	No outcome recorded
Phase 2	NCT05355597	Jan 2021 → Mar 2025	musculoskeletal system disorder, soft tissue neoplasm	Atlantic Health System	Terminated	No outcome recorded
Phase 2	NCT05504967	Dec 2020 → Jul 2023	—	Clinical Academic Center (2CA-Braga)	Completed	No outcome recorded
Phase 2	NCT04250805	Oct 2020 → Jan 2024	cancer, eating disorder	University Hospital of Saint-Etienne	Terminated	No outcome recorded
Phase 2	NCT05016180	Sep 2020 → Nov 2021	—	Tianjin Medical University General Hospital	Unknown	No outcome recorded
Phase 2	NCT04495504	Jul 2020 → Jan 2021	—	University Hospital, Clermont-Ferrand	Completed	No outcome recorded
Phase 2	NCT04182880	Jan → Feb 2020	—	Cali Pharmaceuticals LLC	Completed	No outcome recorded
Phase 2	NCT03149783	Feb 2018 → Aug 2021	delirium, neuropathy, painful	University of Colorado, Denver	Unknown	No outcome recorded
Phase 2	NCT03974035	Jan 2018 → Jan 2020	craniofacial and skeletal defects	Servei Central d'Anestesiologia	Completed	No outcome recorded
Phase 2	NCT03349034	Sep 2017 → Sep 2019	head and neck cancer	Icahn School of Medicine at Mount Sinai	Completed	No outcome recorded
Phase 2	NCT03222323	Jul 2017 → Jan 2018	—	Zealand University Hospital	Unknown	No outcome recorded
Phase 2	NCT03138668	May → Jun 2017	—	Zealand University Hospital	Completed	No outcome recorded
Phase 2	NCT03015532	Jan 2017 → Apr 2018	—	Heron Therapeutics	Completed	No outcome recorded
Phase 2	NCT02884440	Nov 2016 → May 2019	spondylolisthesis	Rennes University Hospital	Completed	No outcome recorded
Phase 2	NCT02784327	Aug 2016 → Apr 2017	—	PainReform LTD	Unknown	No outcome recorded
Phase 2	NCT02431065	May 2015 → May 2016	—	Chungnam National University Hospital	Unknown	No outcome recorded
Phase 2	NCT02270255	Apr 2015 → Nov 2017	leiomyoma	McGill University Health Centre/Research Institute of the McGill University Health Centre	Completed	No outcome recorded
Phase 2	NCT01890408	Nov 2013 → Feb 2014	—	Assistance Publique - Hôpitaux de Paris	Terminated	No outcome recorded
Phase 2	NCT01997593	Nov 2013 → May 2014	neoplasm of testis	Ping Yang	Completed	No outcome recorded
Phase 2	NCT01963299	Aug → Oct 2013	posterior dislocation of lens	Centre Hospitalier Universitaire Dijon	Completed	No outcome recorded
Phase 2	NCT01828788	Apr 2013 → Jan 2015	chronic bronchitis, obesity disorder	University Hospital, Clermont-Ferrand	Completed	No outcome recorded
Phase 2	NCT01855529	Apr 2013 → Aug 2016	—	Centre Jean Perrin	Completed	No outcome recorded
Phase 2	NCT01703351	Oct 2012 → Nov 2015	lung neoplasm	Yonsei University	Completed	No outcome recorded
Phase 2	NCT01575028	Oct 2012 → Jul 2014	appendicitis	Nationwide Children's Hospital	Terminated	No outcome recorded
Phase 2	NCT01681966	Sep 2012 → May 2016	—	PainReform LTD	Completed	No outcome recorded
Phase 2	NCT01452126	Jun → Sep 2011	—	University of New Mexico	Terminated	No outcome recorded
Phase 2	NCT01602250	Jan 2011 → Aug 2013	poisoning	Assistance Publique - Hôpitaux de Paris	Completed	No outcome recorded
Phase 2	NCT00980616	Sep 2009 → Sep 2010	—	University Hospital, Clermont-Ferrand	Completed	No outcome recorded
Phase 2	NCT00210132	Oct 2003 → Jun 2006	cancer	Institut Bergonié	Completed	No outcome recorded

Phase 2/314 trials
Phase 2/3	NCT07290595	Jan 2025 → Feb 2026 overdue	hypotensive disorder	Sahiwal medical college sahiwal	Recruiting	No outcome recorded
Phase 2/3	NCT06519955	Oct 2024 → May 2026 overdue	developmental dysplasia of the hip	Michael C Willey	Recruiting	No outcome recorded
Phase 2/3	NCT05054179	Sep 2022 → Jan 2024	—	University of British Columbia	Unknown	No outcome recorded
Phase 2/3	NCT04669145	Jun 2021 → Apr 2024	musculoskeletal system disorder	Ochsner Health System	Completed	No outcome recorded
Phase 2/3	NCT04513145	Oct 2020 → Dec 2024	osteoarthritis	OrthoCarolina Research Institute, Inc.	Terminated	No outcome recorded
Phase 2/3	NCT03739021	Nov 2019 → Mar 2020 overdue	chronic pain syndrome	University of South Florida	Not yet recruiting	No outcome recorded
Phase 2/3	NCT03260283	Aug 2017 → Nov 2018	—	Saint Savvas Anticancer Hospital	Completed	No outcome recorded
Phase 2/3	NCT03167905	Jun 2017 → Jul 2021 overdue	postpartum depression	KK Women's and Children's Hospital	Active not recruiting	No outcome recorded
Phase 2/3	NCT03316378	Jan 2016 → May 2018	tendinitis	Ruth Chimenti	Completed	No outcome recorded
Phase 2/3	NCT02617199	Nov 2015 → Dec 2016	acute pancreatitis	Hospital General Naval de Alta Especialidad - Escuela Medico Naval	Unknown	No outcome recorded
Phase 2/3	NCT03238430	May 2015 → May 2019	—	University Hospital, Lille	Completed	No outcome recorded
Phase 2/3	NCT02453516	Oct 2014 → Sep 2019	—	Women's College Hospital	Completed	No outcome recorded
Phase 2/3	NCT01743794	Jan 2011	—	University Hospital, Grenoble	Completed	No outcome recorded
Phase 2/3	NCT00586976	Jul 2005 → Jun 2007	—	Mayo Clinic	Terminated	No outcome recorded

Phase 369 trials
Phase 3	NCT06511765	Mar → Sep 2026 expected	lumbar disk disease	Elsan	Recruiting	No outcome recorded
Phase 3	NCT07414706	Mar 2026 → Jun 2028 expected	local anesthetic poisoning	Centre Hospitalier Universitaire, Amiens	Not yet recruiting	No outcome recorded
Phase 3	NCT07076368	Oct 2025 → Jul 2026 overdue	pregnancy disorder	University of California, San Francisco	Recruiting	No outcome recorded
Phase 3	NCT05969457	Sep 2025 → Sep 2029 expected	—	University Hospital, Rouen	Recruiting	No outcome recorded
Phase 3	NCT06875427	Jul 2025 → Jan 2027 expected	—	Isabella Jaramillo	Recruiting	No outcome recorded
Phase 3	NCT07561827	Jun 2025 → Jan 2027 expected	adolescent idiopathic scoliosis	University of California, San Francisco	Recruiting	No outcome recorded
Phase 3	NCT06381622	Apr → Oct 2024	—	Nordsjaellands Hospital	Completed	No outcome recorded
Phase 3	NCT05773846	Mar 2023 → Jul 2024	toe, misshapen	PainReform LTD	Completed	No outcome recorded
Phase 3	NCT05345639	Aug 2022 → Aug 2023	—	University Hospital, Angers	Completed	No outcome recorded
Phase 3	NCT05515809	Jul 2022 → Jun 2025 overdue	—	Centre Hospitalier Universitaire, Amiens	Active not recruiting	No outcome recorded
Phase 3	NCT05463809	Jul 2022 → Jan 2023	tenosynovitis of foot and ankle	Nanjing First Hospital, Nanjing Medical University	Unknown	No outcome recorded
Phase 3	NCT05053087	Apr 2022 → Feb 2023	osteoarthritis, knee	Mayo Clinic	Completed	No outcome recorded
Phase 3	NCT04939545	Dec 2021 → Mar 2023	—	University Hospital, Basel, Switzerland	Completed	No outcome recorded
Phase 3	NCT04702685	Jan → May 2021	neuropathy, painful	Nazarbayev University Medical Center	Unknown	No outcome recorded
Phase 3	NCT04588389	Dec 2020 → May 2021	lumbar disk disease, substance-related disorder	University of Massachusetts, Worcester	Terminated	No outcome recorded
Phase 3	NCT04065009	Aug 2020 → Jan 2024 overdue	ovarian cancer	Karolinska Institutet	Active not recruiting	No outcome recorded
Phase 3	NCT04011150	Aug 2020 → Dec 2025 overdue	—	KK Women's and Children's Hospital	Recruiting	No outcome recorded
Phase 3	NCT04327063	Aug 2020 → Dec 2021	breast cancer	Institut Curie	Completed	No outcome recorded
Phase 3	NCT04222010	Jan 2020 → Feb 2023	—	Centre Hospitalier Universitaire, Amiens	Completed	No outcome recorded
Phase 3	NCT04473508	Nov 2019 → Jun 2021	—	Nîmes University Hospital	Completed	No outcome recorded
Phase 3	NCT03936387	Jul → Sep 2019	neuropathy, painful	Boston Children's Hospital	Completed	No outcome recorded
Phase 3	NCT03984656	Jun 2019 → Sep 2026 expected	—	Centre Hospitalier Universitaire, Amiens	Recruiting	No outcome recorded
Phase 3	NCT02438852	Feb 2019 → Feb 2021	urinary bladder carcinoma	University of Southern California	Withdrawn	No outcome recorded
Phase 3	NCT03688269	Oct 2018 → Nov 2019	—	Centre Hospitalier Universitaire de Besancon	Completed	No outcome recorded
Phase 3	NCT03513445	Jun 2018 → Mar 2022	intervertebral disk degenerative disorder, lumbar disk disease, spondylolisthesis	University of Minnesota	Withdrawn	No outcome recorded
Phase 3	NCT03620136	Feb 2018 → Nov 2019	—	Hospices Civils de Lyon	Completed	No outcome recorded
Phase 3	NCT03084549	Oct 2017 → Nov 2020	—	Centre Hospitalier Departemental Vendee	Completed	No outcome recorded
Phase 3	NCT02959476	Mar 2017 → Aug 2018	neuropathy, painful	BioQ Pharma, Inc.	Completed	No outcome recorded
Phase 3	NCT02949674	Sep → Oct 2016	—	Mexican Social Security Institute	Completed	No outcome recorded
Phase 3	NCT02740127	Jun 2016 → May 2020	male reproductive organ cancer	M.D. Anderson Cancer Center	Completed	No outcome recorded
Phase 3	NCT02655965	May 2016 → Nov 2019	—	Jules Bordet Institute	Completed	No outcome recorded
Phase 3	NCT02682186	Feb 2016 → Oct 2019	—	University Hospital, Montpellier	Completed	No outcome recorded
Phase 3	NCT04482192	Jun 2015 → Jan 2020	—	Zagazig University	Completed	No outcome recorded
Phase 3	NCT02506855	Jun 2015 → Jan 2016	—	University of Mississippi Medical Center	Withdrawn	No outcome recorded
Phase 3	NCT02541552	Apr → Nov 2015	—	London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's	Completed	No outcome recorded
Phase 3	NCT02408393	Mar 2015 → Jul 2018	breast cancer	Institut Curie	Completed	No outcome recorded
Phase 3	NCT02423876	Mar 2015 → Jan 2022	female reproductive organ cancer	University of Wisconsin, Madison	Completed	No outcome recorded
Phase 3	NCT02410317	Feb 2015 → Aug 2021	—	University Hospital, Grenoble	Completed	No outcome recorded
Phase 3	NCT02641288	Jan → Dec 2015	—	Hospital General Universitario Elche	Completed	No outcome recorded
Phase 3	NCT02540070	Aug 2014 → Dec 2017	osteoarthritis, knee	London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's	Unknown	No outcome recorded
Phase 3	NCT02161705	Jul 2014 → Apr 2018	—	Johns Hopkins University	Terminated	No outcome recorded
Phase 3	NCT02154763	Jul 2014 → Jan 2015	—	Ottawa Hospital Research Institute	Completed	No outcome recorded
Phase 3	NCT02353702	Jul 2014 → Jun 2017	—	University Hospital, Rouen	Terminated	No outcome recorded
Phase 3	NCT02112370	May 2014 → May 2016	goiter, thyroid tumor	Seoul National University Hospital	Completed	No outcome recorded
Phase 3	NCT02568995	May 2014 → Sep 2016	—	Örebro University, Sweden	Completed	No outcome recorded
Phase 3	NCT01999153	Dec 2013 → Oct 2018	—	University Hospital, Rouen	Completed	No outcome recorded
Phase 3	NCT02444897	Sep 2013 → Dec 2014	gastric cancer	Keimyung University Dongsan Medical Center	Completed	No outcome recorded
Phase 3	NCT02002663	Aug 2013 → Jun 2016	—	Fondazione IRCCS Policlinico San Matteo di Pavia	Completed	No outcome recorded
Phase 3	NCT02525211	Oct 2012 → Apr 2017	breast cancer	Institut Paoli-Calmettes	Terminated	No outcome recorded
Phase 3	NCT01592630	May 2012 → May 2013	large intestine disorder	Stamford Hospital	Withdrawn	No outcome recorded
Phase 3	NCT02264821	Feb 2012 → Aug 2014	—	Dr Madeleine Wilwerth	Completed	No outcome recorded
Phase 3	NCT02184559	Feb 2012 → Aug 2014	—	Assistance Publique Hopitaux De Marseille	Unknown	No outcome recorded
Phase 3	NCT01623635	Feb → Sep 2012	—	University of Padova	Unknown	No outcome recorded
Phase 3	NCT01432496	Sep 2011 → Dec 2012	—	San Gerardo Hospital	Terminated	No outcome recorded
Phase 3	NCT01318161	Mar 2011 → Dec 2020	colorectal cancer	Örebro University, Sweden	Terminated	No outcome recorded
Phase 3	NCT01367418	Sep 2010 → Mar 2012	prostate cancer	Örebro University, Sweden	Completed	No outcome recorded
Phase 3	NCT01142622	Apr 2010 → Dec 2012	ovarian cyst	San Gerardo Hospital	Completed	No outcome recorded
Phase 3	NCT01077752	Feb 2010 → Jun 2012	neuropathy, painful	Assistance Publique - Hôpitaux de Paris	Completed	No outcome recorded
Phase 3	NCT00927979	Jun 2009 → Jul 2010	—	Carmel Medical Center	Completed	No outcome recorded
Phase 3	NCT00802048	Feb 2009 → Jan 2010	—	University Hospital, Bordeaux	Terminated	No outcome recorded
Phase 3	NCT00825422	Jan 2009 → Apr 2010	—	University Hospital, Bordeaux	Completed	No outcome recorded
Phase 3	NCT01512914	May 2008 → Sep 2009	—	San Gerardo Hospital	Completed	No outcome recorded
Phase 3	NCT01248819	Apr 2008 → May 2009	gallbladder disorder	San Gerardo Hospital	Completed	No outcome recorded
Phase 3	NCT00620490	Mar 2008 → Feb 2009	—	University Hospital, Strasbourg, France	Completed	No outcome recorded
Phase 3	NCT00433316	Feb → Oct 2007	—	Carmel Medical Center	Completed	No outcome recorded
Phase 3	NCT00427947	Dec 2006 → Apr 2009	—	University Hospital, Bordeaux	Terminated	No outcome recorded
Phase 3	NCT00547989	Oct 2006 → Dec 2010	breast cancer	Maastricht University Medical Center	Completed	No outcome recorded
Phase 3	NCT00358280	Apr → Sep 2006	—	AstraZeneca	Completed	No outcome recorded
Phase 3	NCT00197340	Aug 2003 → Dec 2006	fetal growth restriction, preeclampsia	Hadassah Medical Organization	Completed	No outcome recorded

Phase 4177 trials
Phase 4	NCT07497737	Aug 2026 → Apr 2027 expected	frozen shoulder	University Hospitals Cleveland Medical Center	Not yet recruiting	No outcome recorded
Phase 4	NCT07624916	Jun 2026 → Mar 2028 expected	colorectal cancer	Tri-Service General Hospital (TSGH)	Not yet recruiting	No outcome recorded
Phase 4	NCT06054750	Jan → Feb 2026	osteoarthritis, knee	McMaster University	Withdrawn	No outcome recorded
Phase 4	NCT07349810	Jan → Jun 2026 overdue	—	Rutgers, The State University of New Jersey	Recruiting	No outcome recorded
Phase 4	NCT07116343	Oct 2025 → Sep 2027 expected	coronary artery disorder, heart valve disorder	Saint Petersburg State University, Russia	Recruiting	No outcome recorded
Phase 4	NCT05642026	Sep 2025 → Feb 2027 expected	—	Zachary Warriner	Recruiting	No outcome recorded
Phase 4	NCT07145775	Sep 2025 → Jan 2026	—	Peking University First Hospital	Completed	No outcome recorded
Phase 4	NCT07076069	Jul 2025 → Jun 2028 expected	rotator cuff syndrome	Montefiore Medical Center	Recruiting	No outcome recorded
Phase 4	NCT06950372	Feb 2025 → Apr 2026	—	Oslo University Hospital	Completed	No outcome recorded
Phase 4	NCT06779396	Jan → Mar 2025 overdue	—	Beijing Tiantan Hospital	Recruiting	No outcome recorded
Show all 177 trials opens the full record — a long page
Phase not applicable167 trials
—	NCT07591233	Jun 2026 → Mar 2027 expected	gallbladder disorder	Beijing Tiantan Hospital	Recruiting	No outcome recorded
—	NCT07603921	Jun 2026 → May 2027 expected	—	Beijing Tiantan Hospital	Recruiting	No outcome recorded
—	NCT07562945	May → Oct 2026 expected	breast cancer	Aldy Aldy	Not yet recruiting	No outcome recorded
—	NCT07294755	Apr 2026 → May 2027 expected	—	Chinese PLA General Hospital	Not yet recruiting	No outcome recorded
—	NCT07452471	Feb 2026 → Feb 2027 expected	gastric cancer	Gyeong-Jo Byeon, MD, PhD	Not yet recruiting	No outcome recorded
—	NCT07353047	Feb → Sep 2026 expected	—	Northern Jiangsu People's Hospital	Not yet recruiting	No outcome recorded
—	NCT07209345	Oct 2025 → Oct 2026 expected	—	Beijing Tiantan Hospital	Recruiting	No outcome recorded
—	NCT07109388	Sep 2025 → Sep 2027 expected	osteoarthritis, hip	Centre Hospitalier Universitaire Vaudois	Not yet recruiting	No outcome recorded
—	NCT07079436	Aug → Dec 2025 overdue	breast neoplasm	Fudan University	Not yet recruiting	No outcome recorded
—	NCT07099924	Jul 2025 → Aug 2027 expected	colorectal carcinoma, ileus	Asklepios Kliniken Hamburg GmbH	Not yet recruiting	No outcome recorded
Show all 167 trials opens the full record — a long page

Also used as a comparator or background therapy in 631 trials

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 011 trials
Phase 0	NCT07108465 Comparator	Jul → Sep 2025 overdue	impacted teeth, multiple	Henrique Tedesco	Recruiting	No outcome recorded
Phase 0	NCT06299137 Background	Jul 2024 → Dec 2025	substance-related disorder	Rhode Island Hospital	Completed	No outcome recorded
Phase 0	NCT04916691 Background	May 2021 → Aug 2022	—	Mayo Clinic	Completed	No outcome recorded
Phase 0	NCT04413799 Comparator	Sep 2020 → Dec 2024	—	George Washington University	Terminated	No outcome recorded
Phase 0	NCT04263064 Comparator	Mar 2020 → Aug 2022	—	Medical University of South Carolina	Completed	No outcome recorded
Phase 0	NCT04016740 Background	Aug 2019 → Feb 2020	coronary artery disorder, delirium	Beth Israel Deaconess Medical Center	Completed	No outcome recorded
Phase 0	NCT03797924 Comparator	Apr 2019 → Dec 2020	—	University of Florida	Completed	No outcome recorded
Phase 0	NCT02719795 Background	Apr 2016 → Dec 2018	breast neoplasm	First Affiliated Hospital Xi'an Jiaotong University	Unknown	No outcome recorded
Phase 0	NCT02740192 Background	Apr → Dec 2016	—	Henry Ford Health System	Completed	No outcome recorded
Phase 0	NCT02369523 Comparator	Sep 2014 → Apr 2017	—	University of Utah	Terminated	No outcome recorded
Phase 0	NCT01680692 Background	Aug 2012 → Mar 2014	—	Texas Tech University Health Sciences Center, El Paso	Terminated	No outcome recorded

Phase 110 trials
Phase 1	NCT07519109 Comparator	Mar → Dec 2026 expected	—	CSPC Ouyi Pharmaceutical Co., Ltd.	Recruiting	No outcome recorded
Phase 1	NCT06614010 Background	Feb 2023 → Sep 2025 overdue	—	Qianfoshan Hospital	Recruiting	No outcome recorded
Phase 1	NCT04761887 Comparator	Dec 2022	—	Daniel Wambold	Withdrawn	No outcome recorded
Phase 1	NCT05549492 Background	Jan 2021 → May 2022	—	Egymedicalpedia	Completed	No outcome recorded
Phase 1	NCT04551924 Comparator	Oct 2020 → May 2021	—	Jiangsu HengRui Medicine Co., Ltd.	Unknown	No outcome recorded
Phase 1	NCT03935815 Comparator	May 2019 → Jun 2020	uterine corpus leiomyoma	University of California, Los Angeles	Terminated	No outcome recorded
Phase 1	NCT03054610 Comparator	Jan 2015 → Mar 2020	plantar fasciitis, salivary substance, Clostridium botulinum type	Autonomous University of Nuevo León	Completed	No outcome recorded
Phase 1	NCT03200808 Background	Oct 2013 → Oct 2018	vulvar disease	Maternal and Child Health Hospital of Hubei Province	Completed	No outcome recorded
Phase 1	NCT00471692 Comparator	Oct 2006 → Oct 2009	—	Royal Hobart Hospital	Terminated	No outcome recorded
Phase 1	NCT01054547 Comparator	Sep → Dec 2006	—	University of Campinas, Brazil	Completed	No outcome recorded

Phase 1/27 trials
Phase 1/2	NCT07099222 Background	Oct 2024 → Dec 2026 expected	constipation disorder	University of Arizona	Active not recruiting	No outcome recorded
Phase 1/2	NCT05288725 Comparator	Aug 2022 → Jun 2024	osteoarthritis, knee	Next Generation Regenerative Medicine LLC	Unknown	No outcome recorded
Phase 1/2	NCT03970655 Background	Sep 2019 → Jan 2026 overdue	chronic rhinosinusitis	University of Florida	Active not recruiting	No outcome recorded
Phase 1/2	NCT03591146 Comparator	Jul 2018 → Jan 2019	—	Taiwan Liposome Company	Completed	No outcome recorded
Phase 1/2	NCT03195309 Comparator	Jan 2017 → Dec 2018	—	Kaohsiung Medical University Chung-Ho Memorial Hospital	Unknown	No outcome recorded
Phase 1/2	NCT02722746 Comparator	Nov 2016 → Oct 2017	hypotensive disorder	University of Florida	Completed	No outcome recorded
Phase 1/2	NCT01986751 Background	Jan 2014 → Dec 2015	—	University of Alabama at Birmingham	Terminated	No outcome recorded

Phase 230 trials
Phase 2	NCT06559137 Comparator	Sep 2025 → Sep 2027 expected	—	Texas Scottish Rite Hospital for Children	Not yet recruiting	No outcome recorded
Phase 2	NCT06709612 Comparator	Jan 2025 → Mar 2026	—	AmacaThera Inc.	Withdrawn	No outcome recorded
Phase 2	NCT06509958 Comparator	Aug → Oct 2024	—	Shanghai Hengrui Pharmaceutical Co., Ltd.	Terminated	No outcome recorded
Phase 2	NCT06036797 Background	Sep → Oct 2023	—	Maternal and Child Health Hospital of Hubei Province	Unknown	No outcome recorded
Phase 2	NCT05744674 Comparator	Feb → Jun 2023	—	Shanghai Hengrui Pharmaceutical Co., Ltd.	Unknown	No outcome recorded
Phase 2	NCT05487196 Background	Sep 2022 → Jul 2023	pregnancy disorder	Grace Lim, MD, MS	Completed	No outcome recorded
Phase 2	NCT05376904 Comparator	Jun → Oct 2022	—	Shanghai Hengrui Pharmaceutical Co., Ltd.	Completed	No outcome recorded
Phase 2	NCT05901441 Background	Jun 2022 → May 2023	—	Maternal and Child Health Hospital of Hubei Province	Completed	No outcome recorded
Phase 2	NCT05107752 Background	Jan 2022 → Mar 2025	post-traumatic stress disorder	Ohio State University	Completed	No outcome recorded
Phase 2	NCT04559347 Comparator	Dec 2020 → Jan 2024	—	Poovendran Saththasivam	Terminated	No outcome recorded
Phase 2	NCT04182672 Background	Aug 2020 → Dec 2022	—	The University of Texas Health Science Center, Houston	Completed	No outcome recorded
Phase 2	NCT04449289 Comparator	Jul 2020 → Dec 2021	malignant pancreatic neoplasm	Regional Institute of Gastroenterology and Hepatology Prof. Dr. Octavian Fodor	Unknown	No outcome recorded
Phase 2	NCT03977454 Background	Nov 2019 → Jun 2021	arthropathy	Yale University	Completed	No outcome recorded
Phase 2	NCT04161690 Comparator	Nov 2019 → Nov 2020	—	KAT General Hospital	Unknown	No outcome recorded
Phase 2	NCT03838133 Comparator	Mar 2019 → Mar 2020	toe, misshapen	Taiwan Liposome Company	Completed	No outcome recorded
Phase 2	NCT05078372 Comparator	Jan 2019 → Jan 2021	—	Autonomous University of Nuevo León	Completed	No outcome recorded
Phase 2	NCT04178109 Comparator	Jan → Nov 2019	—	KAT General Hospital	Completed	No outcome recorded
Phase 2	NCT03428633 Comparator	Mar 2018 → Feb 2021	—	Asklepieion Voulas General Hospital	Completed	No outcome recorded
Phase 2	NCT02679560 Comparator	Oct 2017 → Nov 2019	—	Ian Elliott Brown	Terminated	No outcome recorded
Phase 2	NCT02616367 Comparator	Dec 2015 → Dec 2016	osteoarthritis, knee	University of Minnesota	Withdrawn	No outcome recorded
Phase 2	NCT03206554 Comparator	Sep 2015 → Mar 2016	—	Asklepieion Voulas General Hospital	Completed	No outcome recorded
Phase 2	NCT02488473 Background	Aug → Sep 2015	—	Zealand University Hospital	Completed	No outcome recorded
Phase 2	NCT02444559 Background	May → Jun 2015	—	Zealand University Hospital	Completed	No outcome recorded
Phase 2	NCT02351804 Comparator	Feb → Mar 2015	—	Rigshospitalet, Denmark	Completed	No outcome recorded
Phase 2	NCT02225054 Background	May 2013 → Mar 2015	arthropathy, neurological pain disorder	Women's College Hospital	Completed	No outcome recorded
Phase 2	NCT01759407 Comparator	May 2013 → Oct 2016	bone disorder	Nationwide Children's Hospital	Terminated	No outcome recorded
Phase 2	NCT02182752 Comparator	Apr 2013 → Jan 2016	rotator cuff syndrome	Asklepieion Voulas General Hospital	Completed	No outcome recorded
Phase 2	NCT02154048 Comparator	Apr 2012 → Sep 2013	—	Duke University	Terminated	No outcome recorded
Phase 2	NCT01293149 Comparator	Apr 2011 → Mar 2013	—	Nationwide Children's Hospital	Withdrawn	No outcome recorded
Phase 2	NCT01242644 Comparator	Oct 2006 → Oct 2009	—	University of South Alabama	Completed	No outcome recorded

Phase 2/315 trials
Phase 2/3	NCT07151417 Background	Sep 2025 → Aug 2026 overdue	osteoarthritis, knee	Walter Reed National Military Medical Center	Not yet recruiting	No outcome recorded
Phase 2/3	NCT05161637 Comparator	Apr → Dec 2025	—	Taiwan Liposome Company	Unknown	No outcome recorded
Phase 2/3	NCT07062497 Background	Jan → Dec 2025 overdue	abdominal wall malformation	Federal University of Rio de Janeiro	Recruiting	No outcome recorded
Phase 2/3	NCT07368075 Background	Jul 2024 → Oct 2025	hypotensive disorder	Sahiwal medical college sahiwal	Completed	No outcome recorded
Phase 2/3	NCT04021264 Comparator	Aug 2019 → Jan 2022	intestinal disorder, liver disorder, pancreas disorder	University of Alberta	Withdrawn	No outcome recorded
Phase 2/3	NCT04020601 Comparator	Aug 2019 → Mar 2020	rotator cuff syndrome	University of Alberta	Terminated	No outcome recorded
Phase 2/3	NCT04022057 Comparator	Aug 2019 → Mar 2020	arthropathy	University of Alberta	Withdrawn	No outcome recorded
Phase 2/3	NCT03533452 Comparator	May 2019 → Jan 2022	rotator cuff syndrome	University of Alberta	Completed	No outcome recorded
Phase 2/3	NCT03746951 Comparator	Apr 2019 → Jan 2020	musculoskeletal system disorder	Nationwide Children's Hospital	Completed	No outcome recorded
Phase 2/3	NCT03069183 Comparator	Aug 2018 → Apr 2022	osteoarthritis, hip	Sunnybrook Health Sciences Centre	Completed	No outcome recorded
Phase 2/3	NCT03098420 Comparator	Jul 2016 → May 2021	—	University of Alabama at Birmingham	Terminated	No outcome recorded
Phase 2/3	NCT02760043 Background	Apr 2016 → Oct 2018	osteoarthritis	University Health Network, Toronto	Unknown	No outcome recorded
Phase 2/3	NCT01558713 Comparator	Jan 2010 → Sep 2012	neonatal compartment syndrome	University of Patras	Unknown	No outcome recorded
Phase 2/3	NCT01582607 Comparator	Jan 2010 → Apr 2012	neonatal compartment syndrome	University of Patras	Unknown	No outcome recorded
Phase 2/3	NCT02185924 Background	Jan 2009 → Sep 2011	—	Asklepieion Voulas General Hospital	Completed	No outcome recorded

Phase 358 trials
Phase 3	NCT07448285 Comparator	Feb 2026 → Feb 2029 expected	chronic pain syndrome	Biobizkaia Health Research Institute	Recruiting	No outcome recorded
Phase 3	NCT07353307 Comparator	Dec 2025 → Apr 2026	—	The Third Xiangya Hospital of Central South University	Completed	No outcome recorded
Phase 3	NCT07092566 Comparator	Nov 2025 → Oct 2027 expected	renal carcinoma	Wake Forest University Health Sciences	Recruiting	No outcome recorded
Phase 3	NCT07469410 Comparator	Jun → Nov 2025	—	Patel Hospital, Pakistan	Completed	No outcome recorded
Phase 3	NCT07429708 Comparator	Mar → Aug 2025	lumbar disk disease	Udayana University	Completed	No outcome recorded
Phase 3	NCT07666178 Comparator	Dec 2024 → Dec 2027 expected	—	Instituto do Coracao	Recruiting	No outcome recorded
Phase 3	NCT06405724 Comparator	May 2024 → Dec 2025	—	Feng Gao	Unknown	No outcome recorded
Phase 3	NCT06379490 Comparator	Apr 2024 → Jun 2025	—	Nordsjaellands Hospital	Completed	No outcome recorded
Phase 3	NCT02712151 Comparator	Mar 2024 → Nov 2026	neuropathy, painful	Boston Children's Hospital	Withdrawn	No outcome recorded
Phase 3	NCT06430112 Comparator	Nov 2023 → May 2024	—	Sun Yat-sen University	Unknown	No outcome recorded
Phase 3	NCT05831449 Comparator	May 2023 → Sep 2025	toe, misshapen	Cali Pharmaceuticals LLC	Completed	No outcome recorded
Phase 3	NCT05813847 Comparator	Apr 2023 → Sep 2025	—	Cali Pharmaceuticals LLC	Completed	No outcome recorded
Phase 3	NCT05769855 Comparator	Mar → Oct 2023	—	Shanghai Hengrui Pharmaceutical Co., Ltd.	Completed	No outcome recorded
Phase 3	NCT05274113 Comparator	Mar 2022 → Mar 2023	—	Rothman Institute Orthopaedics	Unknown	No outcome recorded
Phase 3	NCT04313959 Comparator	Jan 2022 → Feb 2023	chronic pain syndrome	Instituto do Coracao	Unknown	No outcome recorded
Phase 3	NCT04786470 Comparator	May 2021 → Nov 2022	neuropathy, painful	Western University, Canada	Unknown	No outcome recorded
Phase 3	NCT04697537 Comparator	Feb → Apr 2021	osteoarthritis, knee	Medical University of Graz	Completed	No outcome recorded
Phase 3	NCT04717609 Background	Jan 2021 → Jan 2022	arthropathy	Rothman Institute Orthopaedics	Unknown	No outcome recorded
Phase 3	NCT04400721 Comparator	Jul 2020 → Jun 2022	neuropathy, painful	University Hospital Brussels	Unknown	No outcome recorded
Phase 3	NCT04910165 Comparator	Jun 2020 → Sep 2021	arthropathy, substance-related disorder	St. Luke's Hospital, Pennsylvania	Completed	No outcome recorded
Phase 3	NCT04173364 Comparator	Oct 2019 → Sep 2020	respiratory paralysis	University Hospital, Lille	Completed	No outcome recorded
Phase 3	NCT03628040 Comparator	Sep 2019 → Oct 2020	—	London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's	Unknown	No outcome recorded
Phase 3	NCT03768440 Background	Apr 2019 → Feb 2025	—	Boston Children's Hospital	Terminated	No outcome recorded
Phase 3	NCT03586934 Background	Jun 2018 → Jun 2019	substance-related disorder	Rush University Medical Center	Withdrawn	No outcome recorded
Phase 3	NCT03794505 Background	Apr → Aug 2018	—	Mexican Social Security Institute	Completed	No outcome recorded
Phase 3	NCT03187899 Comparator	Apr → Jul 2018	—	University of Alabama at Birmingham	Withdrawn	No outcome recorded
Phase 3	NCT04872322 Comparator	Aug 2017 → Dec 2021	—	Rothman Institute Orthopaedics	Unknown	No outcome recorded
Phase 3	NCT03152929 Comparator	Mar 2017 → May 2019	breast cancer	Corewell Health West	Terminated	No outcome recorded
Phase 3	NCT03151434 Comparator	Feb 2017 → Jul 2018	—	Indiana University	Completed	No outcome recorded
Phase 3	NCT02857465 Background	Jan → Jun 2017	neonatal compartment syndrome, obstetric disorder	Centre Hospitalier Universitaire de la Réunion	Withdrawn	No outcome recorded
Phase 3	NCT03011905 Background	Jan 2017 → Apr 2019	neuropathy, painful	Oslo University Hospital	Completed	No outcome recorded
Phase 3	NCT02862327 Comparator	Dec 2016 → Mar 2017	—	Centre Hospitalier Universitaire de Besancon	Completed	No outcome recorded
Phase 3	NCT02919072 Comparator	Oct 2016 → Jun 2021	—	Sintetica SA	Terminated	No outcome recorded
Phase 3	NCT02819544 Comparator	Sep 2016 → May 2017	—	Centre Hospitalier Universitaire, Amiens	Withdrawn	No outcome recorded
Phase 3	NCT02841488 Comparator	Sep 2016 → Sep 2018	peripheral arterial occlusive disease 1	University of Sao Paulo General Hospital	Unknown	No outcome recorded
Phase 3	NCT03480165 Background	Jun 2016 → Sep 2017	—	Universiti Sains Malaysia	Completed	No outcome recorded
Phase 3	NCT02787018 Comparator	Jun 2016 → Sep 2018	—	B.P. Koirala Institute of Health Sciences	Completed	No outcome recorded
Phase 3	NCT02652156 Comparator	Nov 2015 → Apr 2016	neuropathy, painful	Joshua Herskovic	Terminated	No outcome recorded
Phase 3	NCT02749162 Comparator	Nov 2015 → Feb 2017	—	Foisor Orthopedics Clinical Hospital	Completed	No outcome recorded
Phase 3	NCT02698995 Comparator	Nov 2015 → Feb 2017	—	Foisor Orthopedics Clinical Hospital	Completed	No outcome recorded
Phase 3	NCT02385097 Comparator	Apr 2015 → May 2017	—	Sintetica SA	Completed	No outcome recorded
Phase 3	NCT02821169 Comparator	Apr 2015 → Jun 2019	pain agnosia	University Hospital, Lille	Completed	No outcome recorded
Phase 3	NCT02954484 Comparator	Apr 2015 → May 2017	neuropathy, painful	National University Hospital, Singapore	Completed	No outcome recorded
Phase 3	NCT02278601 Background	Jan 2015 → May 2019 overdue	—	KK Women's and Children's Hospital	Active not recruiting	No outcome recorded
Phase 3	NCT03133481 Comparator	Oct 2014 → Oct 2017	arthropathy	University of Alabama at Birmingham	Completed	No outcome recorded
Phase 3	NCT02256228 Comparator	Oct 2014 → Dec 2017	—	Göteborg University	Completed	No outcome recorded
Phase 3	NCT01971645 Background	Jul 2014 → Jul 2016	osteoarthritis, knee	Nationwide Children's Hospital	Completed	No outcome recorded
Phase 3	NCT01967524 Comparator	Sep 2013 → Aug 2016	myofascial pain syndrome	Nantes University Hospital	Completed	No outcome recorded
Phase 3	NCT03013361 Comparator	Jul 2013 → Dec 2014	—	Post Graduate Institute of Medical Education and Research, Chandigarh	Completed	No outcome recorded
Phase 3	NCT01782781 Comparator	Nov 2012 → Oct 2014	—	Göteborg University	Completed	No outcome recorded
Phase 3	NCT01700491 Comparator	Oct 2012 → Nov 2013	hypotensive disorder	University of Manitoba	Terminated	No outcome recorded
Phase 3	NCT01557270 Comparator	Mar → Nov 2012	—	Prof. Peter Gerner, M.D.	Completed	No outcome recorded
Phase 3	NCT01143025 Comparator	Mar 2010 → Apr 2011	—	San Gerardo Hospital	Completed	No outcome recorded
Phase 3	NCT01082744 Comparator	Mar 2010 → Sep 2014	neuropathy, painful	Hospices Civils de Lyon	Completed	No outcome recorded
Phase 3	NCT01025102 Background	Jan 2010 → Nov 2012	—	Bent Gymoese Jorgensen	Completed	No outcome recorded
Phase 3	NCT00825786 Comparator	Sep 2008 → Aug 2010	—	The Cleveland Clinic	Completed	No outcome recorded
Phase 3	NCT01247857 Comparator	Apr 2008 → Mar 2009	gallbladder disorder	San Gerardo Hospital	Completed	No outcome recorded
Phase 3	NCT00542542 Comparator	Sep 2007 → Mar 2014	breast cancer	M.D. Anderson Cancer Center	Completed	No outcome recorded

Phase 4265 trials
Phase 4	NCT07216586 Comparator	Jan 2027 → Jan 2028 expected	osteoarthritis, knee	University of Miami	Not yet recruiting	No outcome recorded
Phase 4	NCT07631091 Comparator	Jun 2026 → Dec 2027 expected	osteoarthritis, hip	University of Turku	Not yet recruiting	No outcome recorded
Phase 4	NCT07350252 Comparator	Mar 2026 → Mar 2027 expected	osteoarthritis, knee	Region Skane	Recruiting	No outcome recorded
Phase 4	NCT07377630 Comparator	Mar 2026 → Mar 2027 expected	pregnancy disorder	Gaslini Institute	Not yet recruiting	No outcome recorded
Phase 4	NCT07316166 Background	Jan 2026 → Jun 2027 expected	—	Rhode Island Hospital	Recruiting	No outcome recorded
Show all 265 trials opens the full record — a long page
Phase not applicable235 trials
—	NCT07704970 Background	Jul 2026 → Feb 2027 expected	renal cell carcinoma	Huazhong University of Science and Technology	Not yet recruiting	No outcome recorded
—	NCT07677215 Comparator	Jul 2026 → Sep 2027 expected	osteoarthritis, knee	Poznan University of Medical Sciences	Not yet recruiting	No outcome recorded
—	NCT07651722 Comparator	Jun → Sep 2026 expected	paralytic ileus	Tianjin First Central Hospital	Recruiting	No outcome recorded
—	NCT07607535 Comparator	Jun 2026 → Jul 2027 expected	developmental dysplasia of the hip	Poznan University of Medical Sciences	Not yet recruiting	No outcome recorded
—	NCT07607509 Comparator	Jun 2026 → Jul 2027 expected	vertebral column disorder	Poznan University of Medical Sciences	Not yet recruiting	No outcome recorded
Show all 235 trials opens the full record — a long page

Evidence & citations 36 cited values

Every value below carries the sentence it was read from. 1,129 sources stand behind the page.

Field	Value	Cited text
Known as	Ropivacaïne	“The laparoscopic guided TAP Block was performed by surgeon at the beginning of surgery, injecting 15 ml of Ropivacaine 0.5% on each side, using an atraumatic needle (10/15 cm...” NCT06614257 ↗ 1070 “This double-blind, multicenter, randomized, controlled trial study was designed to compare the pharmacokinetics of continuous thoracic epidural infusion of levobupivacaine...” PMID 25977992 ↗ Aug 2015 “Patient undergo elective laparoscopic sleeve gastrectomy will receive 20mL of 150mg ropivacaine (0.75%) diluted in 180mL normal saline to be injected through a catheter along...” NCT03175081 ↗ “This study is to examine the efficacy of continuously via surgically placed intercostal catheter administered ropivacaine at a flow rate of 6-8 ml/h of 2 mg/ml on...” NCT04939545 ↗ “The administered anesthetic mixture will include a fixed dose of fentanyl (15 μg), a variable dose of ropivacaine based on the parturient's somatometric characteristics, and a...” NCT07023497 ↗ “Patient will be given a peripheral nerve block from their treating anesthesiologist before the operation (in the OR) with an conventional ultrasound guided femoral and sciatic...” NCT04697537 ↗ “Following successful catheterization and confirmation of proper placement, a continuous intraoperative infusion of 0.25% ropivacaine was administered via the epidural route to...” NCT07097220 ↗ “Thoracic epidural anesthesia (TEA), the infusion of anesthetic agents (eg, lidocaine or ropivacaine) into the epidural space, is used to achieve sympathetic block at the T1 to...” NCT06068166 ↗ “the intervention group (BRA-CLO) will receive bilateral RSB with a solution containing 8 mL of lidocaine 2%, 8 mL of ropivacaine 1%, and clonidine 75 mcg, diluted in 0.9%...” NCT07062497 ↗ “A single-injection serratus plane block will be administered using ropivacaine 0.5% with epinephrine 1:200,000-400,000 (20 mL of local anesthetic for unilateral surgery; 16 mL...” NCT03860974 ↗ “A standard joint injection of 100ml (Clonidine 80 mcg, Epinephrine 0.5mg, Ketorolac 30mg, Ropivacaine 246.25mg, and Sodium Chloride 0.9% 48.45 ml) will be injected into the...” NCT02682498 ↗ “Patients in group 2 received an adductor canal block with 30 mL of ropivacaine 0.5% with 1:400,000 epinephrine, whereas patients in group 3 received the adductor canal block...” PMID 29315129 ↗ Feb 2018 “Subject will receive 0.2% Ropivacaine at 6-10ml/hour through transversus abdominis plane (TAP) block for up to five days post-operatively in addition to standard of care...” NCT05044429 ↗ “Single Administration of 20 mL of ropivacaine for Serratus plane block (Intra-muscular injection) followed by a single administration of 20 ml ropivacaine for paravertebral...” NCT03852862 ↗ “Thus, the investigators suppose that pre-emptive scalp infiltration with steroid (triamcinolone acetonide) plus local anesthetic (ropivacaine) could relieve postoperative pain...” NCT06069804 ↗ “Thus, the investigators suppose that pre-emptive scalp infiltration with steroid (methylprednisolone) plus local anesthetic (ropivacaine) could relieve postoperative pain after...” NCT04078139 ↗ “an ultrasound guided erector spinae plane catheter with initial bolus of 30 mL of 0.25% bupivacaine followed by infusion of 0.2% ropivacaine at 10 mL per hour via programmed...” NCT06347874 ↗ “In Group E,the thoracic paravertebral block was performed under the direct vision with 0.25% ropivacaine 30 ml,and the Patient-controlled intravenous analgesia was administer...” NCT03449563 ↗ “Subjects randomized to the PVB arm will have an ultrasound-guided paravertebral block performed pre-operatively in the anesthesia block room with 20ml of a ropivacaine /...” NCT03471442 ↗ “Thus, the investigators suppose that pre-emptive scalp infiltration with steroid (diprospan) plus local anesthetic (ropivacaine) could relieve postoperative pain after...” NCT04073069 ↗ “periarticular injection of 50 ml solution which contains ropivacaine 15 mg, epinephrine 0.3 mg, cefmetazole 1000mg, ketorolac 30 mg and morphine HCL 10mg before closure of...” NCT01112436 ↗ “After infiltration with 1 mL of 1% lidocaine, local anesthetics (20 mL of 0.5% ropivacaine) will then be injected in 5 mL aliquots to achieve circumferential spread around the nerve.” NCT02517437 ↗ “one receiving an infiltration "single shot" of local analgesic (Ropivacaïne), one receiving a single shot infiltration and a continuous infiltration of Ropivacaine during 48 hours.” NCT00823576 ↗ “regional block (0.25% ropivacaine 0.5 ml/kg) or caudal block (lower limbs or perineal area: 0.25% ropivacaine 0.5 ml/kg; lower abdomen/inguinal area: 0.25% ropivacaine 0.75 ml/kg)” NCT06816173 ↗ “will receive an ultrasound guided fascia iliaca compartment catheter with initial bolus of 20 mL of 0.5% bupivacaine followed by infusion of 0.2% ropivacaine at 10 mL per hour” NCT06278987 ↗ “injection of ropivacaine 7.5mg / ml is carried out successively in contact with three nerves (ulnar, median and radial) with a volume of 2 ml for nerve, for a total of 45mg.” NCT02610647 ↗ “Morphine 5 mg, ropivacaine 150 mg, tramadol 40 mg, epinephrine 1 mg, ketorolac 60 mg, and ketamine 1 g will be mixed with normal saline to prepare a total volume of 60 ml” NCT06113497 ↗ “5 cc PRP injection (consisting of their own PRP) with 1 cc of 1% lidocaine and 1 cc of 0.5% ropivacaine into the subacromial space, administered by an orthopedic surgeon.” NCT01123889 ↗ “Patients will receive a landmark-guided Erector Spinae Plane Block on the right side at T9 level with 30 mL of 0.25% ropivacaine after induction of general anesthesia.” NCT07469410 ↗ “Subjects will be randomized to receive one of two study solutions in a double-masked manner: either a local anesthetic (ropivacaine 0.5%) or placebo (normal saline).” NCT01824082 ↗ “Next, an anesthetic solution of Ropivacaine 0.375% (dose 37.5 mg) plus Mepivacaine 1% (dose 100 mg) and Dexamethasone 4mg, total volume 21 ml, will be injected.” NCT06155903 ↗ “Hence the present study is aimed to compare the effectiveness of 0.375% levobupivacaine and 0..375% ropivacaine in infra orbital block for cleft palate surgery.” NCT04212611 ↗ “The ropivacaine group will use ultrasound high-frequency line array probe for ACB and convex array probe for iPACK block before induction of general anesthesia” NCT06145165 ↗ “Realization by the anesthesiologist of the local anesthesia by single dose of ropivacaine 0.35% in perinervous under ultrasound with distraction by a tablette.” NCT04846855 ↗ “Intraoperatively: Intravenous Dexamethasone 0.1mg/kg (maximum dose of 8mg), Magnesium 2g, Acetaminophen 1000mg, and local infiltration of 0.5% Ropivacaine 20ml” NCT07076069 ↗ “Solution to be injected will be a combination of Ropivacaine 0.2 % ( 0.5 ml/kg, maximum of 30 ml) and methylprednisolone acetate 1 mg/kg ( maximum of 40 mg ).” NCT03053401 ↗ “The administered dose will include 0.2% lidocaine combined with 0.2% ropivacaine, at a dose of 0.4 ml/kg per side, without exceeding toxic dose limits per kg.” NCT07139691 ↗ “3ml intrathecal starting at a mass of 10 µmol bupivacaine, levobupivacaine or ropivacaine by a combined spinal-epidural analgesia technique (groups A, B, C).” NCT01201213 ↗ “Solutions contain either 0.3% Ropivacaine, 1% Procaine, 0.5% Lidocaine, 0.25% Bupivacaine, or a mixture of 0.25% Bupivacaine and 2% Lidocaine in a 9:1 ratio.” NCT06617065 ↗ “Methylene blue compound injection are mixed by Methylene Blue injection, Dexamethasone powder-injection, Ropivacaine injection and Normal saline injection.” NCT03200808 ↗ “Bilateral TAP catheters (posterior approach) were inserted in 24 healthy volunteers followed by ropivacaine 2 mg/mL administration for a total of 6 hours.” PMID 28319550 ↗ Apr 2017 “followed by ropivacaine 2 mg/ml continous infusion 5-8 ml/h from the end of surgery until end of intervention at the fourth to seventh postoperative day.” NCT03607227 ↗ “loading dose of 0.45 microgram/ml dexmedetomidine plus 0.09% ropivacaine, maintenance dose of 0.36 microgram/ml dexmedetomidine plus 0.07% ropivacaine.” NCT05698407 ↗ “continuous wound inflitration with ropivacaine + tramadol patient-controlled analgesia + additional ketorolac or propacetamol for postoperative 48 hour” NCT02012244 ↗ “For treatment delivery, subjects will receive 60 mL of 0.25 percent ropivacaine with 4 mg of dexamethasone either at the initiation of the procedure” NCT05753046 ↗ “One hundred sixteen patients were randomly assigned to either the BR (Betamethasone-Ropivacaine) group or the R (Ropivacaine) group in a 1:1 ratio.” PMID 37800559 ↗ Jan 2024 “consists of 7-10 mL of ropivacaine 0.5%, which is injected around and into the site of the ganglion at the level of the C4 and C6 anterior tubercle” NCT05107752 ↗ “Epidural anesthesia placed at L1-L2 Epidural infusion of ropivacaine 0.2% + 3-4 mcg/ml fentanyl + saline 0.9% (100 ML) 3-5ml/ hr during 120 hours” NCT02617199 ↗ “A single injection of 20mL of ROPIVACAINE 2mg / ml, the efficacy of which should be checked before spinal anesthesia is performed by a cold test.” NCT03620136 ↗ “Patients underwent ultrasound-guided interscalene blocks using either 12 mL of 0.5% ropivacaine or 0.5% ropivacaine plus 150-µg dexmedetomidine.” PMID 24317234 ↗ Jan 2014 “Bilateral ESPB under ultrasound guidance bi-level Th3-6 and Th9-L1(adjusted to the incision line): 0.3-0.5ml/kg 0.2% Ropivacaine (max 2.5mg/kg)” NCT05938959 ↗ “Ropivacaine perineal infiltration for postpartum pain management in episiotomy repair: a double-blind, randomised, placebo-controlled trial.” PMID 35876236 ↗ Aug 2022 “a bolus of 20 ml 0.5% Ropivacaine will be injected under direct visualization in 5 mL aliquots ensuring proper placement of the needle tip.” NCT03133481 ↗ “Patient will receive Tap Block to 15ml of 0.5% Ropivacaine and will be administered the following Narcotic Pain Regimen post-operatively:” NCT05231460 ↗ “This study is to evaluate the safety and tolerability of single dose of GB-6002 (Ropivacaine) Local Infiltration in healthy male Adults.” NCT06095973 ↗ “20mL of 0.25% Ropivacaine with Epinephrine 1:200,000 is injected into bilateral transversus abdominal planes under ultrasound guidance.” NCT01479270 ↗ “The control for this study will be a High Volume-Low Concentration (1.5cc/kg of 0.15% ropivacaine and 5mcg/cc epinephrine) caudal block” NCT04263064 ↗ “A total of ropivacaine 75mg will be injected into the plane via the needle, followed by placement of a catheter 3-5 cm into the plane.” NCT06519929 ↗ “Thoracic epidural catheterization will be performed and epidural anesthesia will be maintained with 0.25% ropivacaine during surgery.” NCT03245346 ↗ “For ESP group, an ultrasound guided ESP Block was perormed before anesthetic induction with injection of 30 ml of Ropivacaine 3.75%.” NCT06383845 ↗ “500 ml of 0.2 % ropivacaine connected to the catheter after the end of the surgery, administered continuously at a rate of 10 mL/hr” NCT04852484 ↗ “Intra-articular injection consisting of 80 mg of methylprednisolone acetate, 2 mL of lidocaine (1%), and 4 mL of ropivacaine (0.5%)” NCT07497737 ↗ “All patients will receive the same type and amount of local anesthetic: 30 ml of a mixture of ropivacaine 0.5 % + mepivacaine 1 %.” NCT03378323 ↗ “This injection may be followed with up to 3mL of ropivacaine (depending on the capacity of the bursa), under ultrasound guidance.” NCT04182672 ↗ “Patients in this group will receive an interscalene nerve block containing the local anesthetic ropivacaine prior to surgery.” NCT02762071 ↗ “Patients undergoing TKA received a femoral perineural infusion of ropivacaine 0.2% from surgery until the following morning” PMID 19299806 ↗ Apr 2009 “The aim of the study is to Evaluate of the analgesic effect of ropivacaine in topical use at the thin skin graft donor site.” NCT01999153 ↗ “The patient in Group I will be given caudal epidural injection with 0.25% ropivacaine 20 ml containing dexamethasone 8 mg” NCT05904275 ↗ “performed bilateral superficial cervical plexus block with 0.5% ropivacaine and injected 3-4ml at two points respectively” NCT05577962 ↗ “Group 1 will receive 15 ml of a Ropivacaine 0,75% solution through the femoral catheter (femoral group = 300 Patients).” NCT03092466 ↗ “Thoracic paravertebral block using local anesthetic (e.g., ropivacaine) for intraoperative and postoperative analgesia.” NCT07409129 ↗ “From periarticular injection consisted of 400 mg ropivacaine, 5 mg morphine and 0.4 mg epinephrine in 50 cc solution.” NCT06557018 ↗ “stellate ganglion block will be administered using either 6-8mL saline (Group 1) or 0.25% ropivacaine 6-8mL (Group 2)” NCT02275247 ↗ “0.2% ropivacaine combined with either normal saline (control), dexamethasone 0.05 mg/kg, or dexamethasone 0.1 mg/kg” PMID 41940446 ↗ Apr 2026 “* Ropivacaine: Given intraoperatively. Capsule, subcutaneous tissue/skin. Administered in standard fashion. (300mg)” NCT02219581 ↗ “Morphine, epinephrine, and ropivacaine cocktail will be administered peri-incisionally during lumbar spine surgery.” NCT03513445 ↗ “Epidural analgesia was continued for next 24 hours with a mixture of ropivacaine 2.2 mg/ml and morphine 0.4 mg/ml.” NCT04587505 ↗ “biliteral administration of 20ml of 0,2% ropivacaine + 2ml 0.9% sodium chloride for the erector spine plane block” NCT06233617 ↗ “During general anesthesia, a celiac plexus block will be performed intraoperatively (20 ml of 0.5% ropivacaine).” NCT06793527 ↗ “Ropivacaine 0.5% (with epinephrine 1:200,000-400,000) will be administered via the needle into the target plane.” NCT03549234 ↗ “Bilateral ultrasound guided injection of local anesthetic (ropivacaine 0.35%, 40ml) in the erector spinae plane” NCT05271331 ↗ “30mL of ropivacaine 0.375%, with or without 4mg of dexamethasone are injected, according to the randomization.” NCT02436694 ↗ “administration of 0.5ml/kg of 0.2% ropivacaine with 0.1ug/kg Dexmedetomidine for the erector spine plane block” NCT06789016 ↗ “ropivacaine 0.2% administration as either a basal infusion (8 mL/h) or bolus doses (8 mL administered hourly).” NCT02219438 ↗ “Intervention Group: Ultrasound guided rectus sheath block with 0.5% ropivacaine 20ml at each side (bilateral)” NCT05984212 ↗ “administration of 0.5ml/kg of 0,2% ropivacaine + 0.01ml/kg 0.9% sodium chloride for the popliteal nerve block” NCT06233565 ↗ “Pudendal nerve block (PNB) with ropivacaine AND Patient-controlled sedation with propofol by the participant” NCT06044103 ↗ “Comparison Between the Use of Ropivacaine Alone and Ropivacaine With Sufentanil in Epidural Labor Analgesia.” PMID 26512604 ↗ Oct 2015 “administration of 0.5ml/kg of 0.2% ropivacaine with 0.1mg/kg Dexamethasone for the erector spine plane block” NCT06616220 ↗ “Intercostal nerve block consists in the injection of Ropivacaine (4 ml,0.5%) in related intercostal spaces.” NCT03682354 ↗ “Bupivacaine 0.3% \[or ropivacaine 0.5%\] infusions for 7 days via femoral and sciatic perineural catheters” NCT03461120 ↗ “a 5 mL combination of 1 mL of 40 mg/mL triamcinolone, 2 mL of 0.2% ropivacaine, and 2 mL of normal saline” NCT07278323 ↗ “With either the single shot or the catheter the local numbing medication called ropivacaine will be used.” NCT02106481 ↗ “The Ropivacaïne group received 3mg/kg of 0.375% ropivacaïne(0.75% ropivacaïne, Astra, mixed with saline)” NCT00370240 ↗ “Intra-operatively: Bupivacaine 0.5% with adrenaline Post-operatively: Ropivacaine 0.2% + sufentanil 1 ug” NCT01367418 ↗ “The first group received an ultrasound-guided fascia iliaca block with 50 to 60 mL of 0.35% ropivacaine.” PMID 31999469 ↗ Jan 2020 “The anesthetist prepares two sy-ringes with 20 ml each with ropivacaine 0.25% with 75 μg of clonidine.” NCT07377630 ↗ “Group 1 - 20mls 0.5% ropivacaine for ilio inguinal nerve block and 20mls saline for wound irrigation.” NCT00471692 ↗ “Ketorolac 30 mg, Morphine PF 5 mg, Epinephrine 0.6 mg, Ropivacaine 400 mg, QS to 100ml with 0.9% NaCl” NCT02299349 ↗ “Subjects will be given a rectus sheath block containing dexmedetomidine, ropivacaine, and ketorolac” NCT03817034 ↗ “Ropivacaine or levobupivacaine was infused intravenously in 16 volunteers (8 mg/min up to 120 mg)” PMID 27404223 ↗ Sep 2016 “The control group will receive a femoral nerve block and postoperative ropivacaine 0.2% infusion” NCT01759277 ↗ “A single injection of 30 mL of Ropivacaine 4.75 mg / mL is performed around the Serratus muscle.” NCT03984656 ↗ “ropivacaine (Naropin) 0.2% according to a protocol 8-10 cc per hour up to 24 hours after surgery” NCT06382285 ↗ “Ropivacaine and Exparel both work well for postoperative pain after total shoulder replacement.” NCT02787226 ↗ “the physician will inject 2cc of the PL and 1cc of 0.5% ropivacaine into the epidural space.” NCT03618979 ↗ “Epinephrine 1mg (1mL), 0.5% ropivacaine (60mL), Acetaminophen 1000mg IV, Toradol 30mg (1ml)” NCT06113211 ↗ “In Group pre, RSB and ICNB are performed with 0.25% Ropivacaine 40ml before the operation.” NCT03413280 ↗ “Single shot TAP block is performed using 30ml 0.5% ropivacaine at the end of the case.” NCT02475031 ↗ “brachial plexus block with perineural injection of Ropivacaine in the axillary fossa” NCT02862327 ↗ “25 ml of 0.5% ropivacaine with 1:200,000 adrenaline will be drawn in a 25 ml syringe” NCT06490718 ↗ “Normal saline 0.5mL added to ropivacaine 0.15% 1.0 ml/kg was administered to Group R” NCT01679353 ↗ “Erector Spinae Plane Block with 0.2% Ropivacaine + 0.1mg/kg perineural Dexamethasone” NCT06789029 ↗ “Intrafascial injection of clonidine, epinephrine, ropivacaine, and toradol solution” NCT06935331 ↗ “Wound infiltration with 10mL of ropivacaine 0.75%, in open inguinal hernia repair” NCT03534895 ↗ “100 mg of ropivacaine is then deposited in this plane, lifting the psoas tendon.” NCT05673486 ↗ “ropivacaine 100 mg + 150 mcg dexmedetomidine, single shot perineural application” NCT01557270 ↗ “Subcutaneous infiltration during surgery using 200ml of 0.2% plain ropivacaine.” NCT02478372 ↗ “A 20 ml bolus of 0.2% Ropivacaine will be given via a femoral nerve catheter.” NCT00869037 ↗ “the PVB group received ropivacaine 0.5% injected in the paravertebral space” PMID 25427288 ↗ May 2015 “Ultrasound guided popliteal sciatic nerve block with 0.2% ropivacaine 20ml” NCT03414593 ↗ “local anesthetic (ropivacaine 0.2%, 2.0 mL or bupivacaine 0.25%, 2.0 mL)” NCT07431944 ↗ “tracheal spray with 0.8% ropivacaine 40 mg (5 mL) for surface anesthesia” NCT06952309 ↗ “a fixed dose of ropivacaine for continuous femoral nerve block after TKA” PMID 23928707 ↗ May 2014 “Ropivacaïne 5 mg/mL (not to exceed 3 mg/kg and 30 ml of maximal volume)” NCT04327063 ↗ “25 ml of 0.35% ropivacaine is slowly injected with repeated aspiration.” NCT02784041 ↗ “inject 20ml of 0.5% ropivacaine (Hengrui, Jiangsu) into the TPV space.” NCT06135545 ↗ “US-guided TFP block with 20ml 0.5% ropivacaine + 1:200 000 epinephrine” NCT01133730 ↗ “0.5% ropivacaine injected under ultrasound guidance into the axilla.” NCT03135340 ↗ “Pre-operative adductor canal nerve block (20mL of 0.5% ropivacaine).” NCT02219087 ↗ “Standard epidural placement. Ropivacaine 0.1% and Fentanyl 2mcg/mL.” NCT03074695 ↗ “injecting the numbing medicine ropivacaine into the surgical site” NCT04184349 ↗ “One receiving ropivacaine, one receiving liposomal bupivacaine.” NCT04801368 ↗ “with low-dose ropivacaine to decrease early postoperative pain” PMID 24764186 ↗ Apr 2014 “CPL-01 is a novel extended-release formulation of ropivacaine.” PMID 39881115 ↗ Jan 2025 “transversus abdominis plane block with 20 mL 0.25% ropivacaine” NCT02219542 ↗ “3 mg/kg of ropivacaine 0.5% sprayed into the abdominal cavity” NCT05173090 ↗ “150mL 2% Ropivacaine, 30mg Ketorolac and 0.6mg of Epinephrine” NCT02760043 ↗ “0.2% ropivacaine 5ml epidural injection every 4 hours per day” NCT02391142 ↗ “about 15 ml Ropivacaine 0,75% around the carotid bifurcation” NCT03081897 ↗ “All patients received ropivacaine through elastomeric pump” NCT04985695 ↗ “Local anesthetic injection (ropivacaine) at this new site” NCT03653000 ↗ “Ropivacaine 0.2% infusion through adductor canal catheter” NCT05100706 ↗ “local anesthetic (ropivacaine) around the saphenous nerve” NCT06784882 ↗ “Interscalene Block with Ropivacaine Hcl 0.2% Inj Vil 10Ml” NCT03081728 ↗ “Individualized analgesia with sufentanil and ropivacaine” NCT02920489 ↗ “All participants will receive 20 mL of 0.2% ropivacaine.” NCT07327931 ↗ “using ropivacaine, epinephrine, ketorolac, and morphine” PMID 24706022 ↗ Jan 2015 “20 ml of ropivacaine 0.2% every 8 hour in the catheter” NCT03142789 ↗ “Ropivacaine 0.2% Ketorolac 30 mg Adrenaline 0.1 mg/ml” NCT01281891 ↗ “Ropivacaine (Brand Name: Naropin) 5 mg/ml (49.25 ml)” NCT02571283 ↗ “Topical use of Ropivacaine in laparoscopic surgery” NCT02826876 ↗ “Epidural anesthesia is performed with ropivacaine.” NCT03012945 ↗ “30ml of 0.35% ropivacaine with 1:400K epinephrine” NCT04860843 ↗ “peripheral nerve block utilizing ropivacaine 0.2%” NCT05506930 ↗ “If \< 1 year old Ropivacaine 0.1% 0.25 mg/kg/side” NCT03593642 ↗ “combination of ropivacaine 0.5% and lidocaine 2%” NCT04180943 ↗ “a combination of ropivacaine and dexmedetomidine” NCT03677115 ↗ “rectus sheath block with 0.375% ropivacaine” NCT02827097 ↗ “Single injection of 20 ml ropivacaine 0.5%” NCT01355757 ↗ “The drug used is Ropivacaine 2mg/ml, 0.2%.” NCT05515809 ↗ “0.3ml/kg of ropivacaine 0.10% (max 10 ml)” NCT00413582 ↗ “Wound infiltration: Ropivacaine 75-150mg” NCT04894864 ↗ “epidural catheter with 0.3% ropivacaine” NCT01900626 ↗ “20ml 0.2% Ropivacaine + 2.0ml 0.9% NaCl” NCT06789042 ↗ “10 to 30cc of ropivacaine (2 to 3,75 %)” NCT04585126 ↗ “10ml of 0.3% ropivacaine was injected.” NCT06120439 ↗ “injecting 5 ml of 0.375% ropivacaine.” NCT05652179 ↗ “Ropivacaine Hcl 0.5% Injection 40 mL” NCT03405922 ↗ “Ropivacaine Surgical ward: Morphine” NCT05172739 ↗ “49.25ml 0.5% ropivacaine (5mg/ml)” NCT07151417 ↗ “nerve block with 0.5% ropivacaine” NCT06720285 ↗ “QL block with 0.25% ropivacaine” NCT05247255 ↗ “1. Ropivacaine 0.5% - 30 ml” NCT03105674 ↗ “Low dose of Ropivacaine HCl” NCT05411861 ↗ “block with only ropivacaine” NCT03570645 ↗ “20-30 mL 0.5% Ropivacaine” NCT03152929 ↗ “Injection of Ropivacaine” NCT04311099 ↗ “5 ml of 0.5% ropivacaine” NCT01555216 ↗ “40ml Ropivacaine 0.2%” NCT05345639 ↗ “Ropivacaine” NCT02197273 ↗ NCT06981949 ↗ NCT02398474 ↗ NCT02406300 ↗ NCT07108465 ↗ NCT04065009 ↗ NCT03961048 ↗ NCT02289937 ↗ NCT06008795 ↗ NCT02967172 ↗ NCT01077752 ↗ NCT03230565 ↗ NCT06304298 ↗ NCT03533452 ↗ NCT06779396 ↗ NCT00864409 ↗ NCT00987441 ↗ NCT03476642 ↗ NCT00370240 ↗ NCT04062045 ↗ NCT05624359 ↗ NCT03404908 ↗ NCT05205720 ↗ NCT03721406 ↗ NCT01898689 ↗ NCT02336958 ↗ NCT07023094 ↗ NCT07023107 ↗ NCT07109388 ↗ NCT03054610 ↗ NCT04726280 ↗ NCT04934904 ↗ NCT01537146 ↗ NCT02919072 ↗ NCT07023120 ↗ NCT06302218 ↗ NCT05023343 ↗ NCT02201784 ↗ NCT02607579 ↗ NCT03586934 ↗ NCT02108847 ↗ NCT04872322 ↗ NCT05820997 ↗ NCT07448285 ↗ NCT02408393 ↗ NCT05343299 ↗ NCT02817321 ↗ NCT00632580 ↗ NCT01987128 ↗ NCT02331030 ↗ NCT02439281 ↗ NCT02663284 ↗ NCT04313959 ↗ NCT02374008 ↗ NCT05889741 ↗ NCT02488291 ↗ NCT00815503 ↗ NCT03302221 ↗ NCT01843153 ↗ NCT06430112 ↗ NCT00912873 ↗ NCT07449403 ↗ NCT02330302 ↗ NCT07449468 ↗ NCT02863120 ↗ NCT05423132 ↗ NCT01986751 ↗ NCT02606448 ↗ NCT00678314 ↗ NCT00552864 ↗ NCT05024344 ↗ NCT07452471 ↗ NCT02488473 ↗ NCT04380298 ↗ NCT01615939 ↗ NCT05625802 ↗ NCT03480165 ↗ NCT02712151 ↗ NCT04868058 ↗ NCT07677215 ↗ NCT02543801 ↗ NCT06565910 ↗ NCT06006026 ↗ NCT02198547 ↗ NCT03238430 ↗ NCT00523289 ↗ NCT02410317 ↗ NCT02861950 ↗ NCT04051723 ↗ NCT03650998 ↗ NCT03588689 ↗ NCT04051684 ↗ NCT06498583 ↗ NCT02818140 ↗ NCT03353233 ↗ NCT03302689 ↗ NCT05068661 ↗ NCT06393530 ↗ NCT02961361 ↗ NCT06214533 ↗ NCT05897307 ↗ NCT02139982 ↗ NCT02751268 ↗ NCT03730584 ↗ NCT02971540 ↗ NCT01075646 ↗ NCT02871193 ↗ NCT03222323 ↗ NCT07209345 ↗ NCT05504967 ↗ NCT07368075 ↗ NCT02818491 ↗ NCT04048889 ↗ NCT07562945 ↗ NCT02483923 ↗ NCT02144766 ↗ NCT04938882 ↗ NCT06145945 ↗ NCT02023684 ↗ NCT04245280 ↗ NCT02236130 ↗ NCT05688670 ↗ NCT04074265 ↗ NCT04717609 ↗ NCT06781632 ↗ NCT05016180 ↗ NCT01082744 ↗ NCT05015907 ↗ NCT05345249 ↗ NCT01117610 ↗ NCT02326727 ↗ NCT01575028 ↗ NCT02436265 ↗ NCT04860856 ↗ NCT07290595 ↗ NCT04047745 ↗ NCT02341144 ↗ NCT01840800 ↗ NCT01234272 ↗ NCT07561827 ↗ NCT01248819 ↗ NCT01890408 ↗ NCT02375191 ↗ NCT01247857 ↗ NCT04077398 ↗ NCT00771459 ↗ NCT01111513 ↗ NCT01075087 ↗ NCT07216586 ↗ NCT03645304 ↗ NCT05173090 ↗ NCT06299137 ↗ NCT02171299 ↗ NCT03219983 ↗ NCT02571439 ↗ NCT04247373 ↗ NCT04248179 ↗ NCT04046744 ↗ NCT01620047 ↗ NCT05596071 ↗ NCT02256228 ↗ NCT01196767 ↗ NCT02959476 ↗ NCT03167905 ↗ NCT01261689 ↗ NCT02749162 ↗ NCT02819544 ↗ NCT03244540 ↗ NCT02067078 ↗ NCT01172197 ↗ NCT02924324 ↗ NCT03099720 ↗ NCT02604550 ↗ NCT05248724 ↗ NCT03734159 ↗ NCT05807945 ↗ NCT05463809 ↗ NCT01704612 ↗ NCT04317235 ↗ NCT07666178 ↗ NCT03117140 ↗ NCT02873091 ↗ NCT03057015 ↗ NCT01160965 ↗ NCT03812731 ↗ NCT07704970 ↗ NCT03955458 ↗ NCT00433316 ↗ NCT02764723 ↗ NCT02603900 ↗ NCT03874806 ↗ NCT05336968 ↗ NCT06640621 ↗ NCT07099924 ↗ NCT01993290 ↗ NCT02541552 ↗ NCT03875274 ↗ NCT04173364 ↗ NCT02957903 ↗ NCT04786470 ↗ NCT03365908 ↗ NCT06559137 ↗ NCT02112370 ↗ NCT07116343 ↗ NCT03117894 ↗ NCT06701539 ↗ NCT01943240 ↗ NCT07099222 ↗ NCT05901441 ↗ NCT04161690 ↗ NCT01074229 ↗ NCT03737604 ↗ NCT05376904 ↗ NCT05953766 ↗ NCT02323282 ↗ NCT07294755 ↗ NCT03118076 ↗ NCT05877131 ↗ NCT03738696 ↗ NCT05175001 ↗ NCT04250805 ↗ NCT03098420 ↗ NCT05091905 ↗ NCT03739021 ↗ NCT04085237 ↗ NCT05693467 ↗ NCT03214536 ↗ NCT02344264 ↗ NCT02857465 ↗ NCT02768493 ↗ NCT04391855 ↗ NCT00720330 ↗ NCT00901628 ↗ NCT03367728 ↗ NCT00547989 ↗ NCT02925832 ↗ NCT01511211 ↗ NCT03970655 ↗ NCT03119038 ↗ NCT02080728 ↗ NCT01328782 ↗ NCT02540070 ↗ NCT02570503 ↗ NCT05012137 ↗ NCT01054547 ↗ NCT03809442 ↗ NCT04555291 ↗ NCT06570538 ↗ NCT03867695 ↗ NCT06557044 ↗ NCT02414373 ↗ NCT03487874 ↗ NCT07474896 ↗ NCT04222010 ↗ NCT02264821 ↗ NCT02293525 ↗ NCT02539628 ↗ NCT06023329 ↗ NCT02494336 ↗ NCT02658240 ↗ NCT01703351 ↗ NCT05817162 ↗ NCT04737980 ↗ NCT05767749 ↗ NCT02576015 ↗ NCT04449289 ↗ NCT05556122 ↗ NCT05767827 ↗ NCT03971708 ↗ NCT04558281 ↗ NCT02616367 ↗ NCT02658149 ↗ NCT07651722 ↗ NCT05944393 ↗ NCT04879004 ↗ NCT04559347 ↗ NCT05944380 ↗ NCT00927225 ↗ NCT01815944 ↗ NCT07061678 ↗ NCT06230003 ↗ NCT06608810 ↗ NCT04034836 ↗ NCT03864588 ↗ NCT05995301 ↗ NCT01512914 ↗ NCT03704753 ↗ NCT00680823 ↗ NCT01293149 ↗ NCT03372265 ↗ NCT03598192 ↗ NCT02479828 ↗ NCT02173418 ↗ NCT03372304 ↗ NCT02657291 ↗ NCT06636578 ↗ NCT04513145 ↗ NCT02576223 ↗ NCT02821169 ↗ NCT01541059 ↗ NCT03704376 ↗ NCT02954484 ↗ NCT01171885 ↗ NCT02914015 ↗ NCT01997567 ↗ NCT05161637 ↗ NCT02082067 ↗ NCT03046290 ↗ NCT00992082 ↗ NCT07577934 ↗ NCT07429708 ↗ NCT01997593 ↗ NCT02208245 ↗ NCT03293472 ↗ NCT05744674 ↗ NCT04257682 ↗ NCT05160298 ↗ NCT02576249 ↗ NCT00519584 ↗ NCT06785350 ↗ NCT02513433 ↗ NCT03572686 ↗ NCT00980616 ↗ NCT02851888 ↗ NCT05871073 ↗ NCT03901612 ↗ NCT02570022 ↗ NCT07271979 ↗ NCT04562103 ↗ NCT03571490 ↗ NCT04702685 ↗ NCT07478692 ↗ NCT03600129 ↗ NCT04849455 ↗ NCT02346357 ↗ NCT02267044 ↗ NCT05555147 ↗ NCT00799175 ↗ NCT01388946 ↗ NCT06574269 ↗ NCT03309163 ↗ NCT02444559 ↗ NCT00900913 ↗ NCT07353307 ↗ NCT06950372 ↗ NCT07425678 ↗ NCT03974035 ↗ NCT03702647 ↗ NCT03824717 ↗ NCT01582607 ↗ NCT02655965 ↗ NCT02707874 ↗ NCT02114463 ↗ NCT02980835 ↗ NCT05297422 ↗ NCT03746951 ↗ NCT02849678 ↗ NCT03657979 ↗ NCT03206554 ↗ NCT02719795 ↗ NCT04178109 ↗ NCT03570541 ↗ NCT00891540 ↗ NCT07353047 ↗ NCT02444897 ↗ NCT02849236 ↗ NCT05868993 ↗ NCT01086956 ↗ NCT00603083 ↗ NCT04508504 ↗ NCT07092566 ↗ NCT02175069 ↗ NCT02808728 ↗ NCT00197340 ↗ NCT01480089 ↗ NCT06389617 ↗ NCT05696678 ↗ NCT05824338 ↗ NCT02059070 ↗ NCT02369523 ↗ NCT04567407 ↗ NCT02680626 ↗ NCT03413371 ↗ NCT01012232 ↗ NCT02848287 ↗ NCT06083428 ↗ NCT04394130 ↗ NCT01740453 ↗ NCT07423910 ↗ NCT05437835 ↗ NCT04155983 ↗ NCT03805360 ↗ NCT01679392 ↗ NCT03906838 ↗ NCT02848157 ↗ NCT06925789 ↗ NCT03376178 ↗ NCT07196631 ↗ NCT02084368 ↗ NCT02554864 ↗ NCT05908851 ↗ NCT06218160 ↗ NCT00573963 ↗ NCT04302181 ↗ NCT02419261 ↗ NCT03700177 ↗ NCT02682186 ↗ NCT02884440 ↗ NCT06819748 ↗ NCT02270255 ↗ NCT01939379 ↗ NCT03128216 ↗ NCT05274113 ↗ NCT02270437 ↗ NCT00722709 ↗ NCT01194843 ↗ NCT03041935 ↗ NCT02983344 ↗ NCT06668116 ↗ NCT06953661 ↗ NCT01623635 ↗ NCT01042093 ↗ NCT02085239 ↗ NCT06035692 ↗ NCT04394481 ↗ NCT03541837 ↗ NCT02653144 ↗ NCT02477098 ↗ NCT04368364 ↗ NCT02740192 ↗ NCT01432496 ↗ NCT01999647 ↗ NCT01681966 ↗ NCT03698006 ↗ NCT02740127 ↗ NCT02476799 ↗ NCT02393677 ↗ NCT06036797 ↗ NCT01971645 ↗ NCT02085902 ↗ NCT07087015 ↗ NCT02721290 ↗ NCT03977454 ↗ NCT02512471 ↗ NCT07349810 ↗ NCT02154048 ↗ NCT03563963 ↗ NCT02568995 ↗ NCT01304212 ↗ NCT01644864 ↗ NCT02778178 ↗ NCT02619513 ↗ NCT02000973 ↗ NCT05700214 ↗ NCT04266236 ↗ NCT00562627 ↗ NCT03497364 ↗ NCT00620490 ↗ NCT06671028 ↗ NCT02056288 ↗ NCT05368753 ↗ NCT03696095 ↗ NCT01872494 ↗ NCT04208516 ↗ NCT04575233 ↗ NCT03756987 ↗ NCT07414706 ↗ NCT02351804 ↗ NCT02523235 ↗ NCT01119209 ↗ NCT01559285 ↗ NCT03695172 ↗ NCT01643616 ↗ NCT01005550 ↗ NCT03038425 ↗ NCT03084549 ↗ NCT06114121 ↗ NCT01726686 ↗ NCT06062134 ↗ NCT03154658 ↗ NCT01052974 ↗ NCT07631091 ↗ NCT03086213 ↗ NCT02055664 ↗ NCT03260283 ↗ NCT02950558 ↗ NCT05769855 ↗ NCT04690023 ↗ NCT03636165 ↗ NCT00964639 ↗ NCT02523755 ↗ NCT01700491 ↗ NCT05216055 ↗ NCT02722096 ↗ NCT02154763 ↗ NCT00702416 ↗ NCT01558713 ↗ NCT00289419 ↗ NCT05487196 ↗ NCT03381495 ↗ NCT03083080 ↗ NCT04327063 ↗ NCT05294393 ↗ NCT01589354 ↗ NCT01170702 ↗ NCT04022057 ↗ NCT04298099 ↗ NCT02641288 ↗ NCT07131657 ↗ NCT02164929 ↗ NCT01344395 ↗ NCT02652156 ↗ NCT02932930 ↗ NCT04021264 ↗ NCT02002663 ↗ NCT03035656 ↗ NCT06709612 ↗ NCT07626489 ↗ NCT05825378 ↗ NCT05078372 ↗ NCT04494100 ↗ NCT07626463 ↗ NCT02949778 ↗ NCT01743794 ↗ NCT04020601 ↗ NCT02949674 ↗ NCT02314104 ↗ NCT02353182 ↗ NCT04493463 ↗ NCT02722746 ↗ NCT05442411 ↗ NCT02353702 ↗ NCT03134729 ↗ NCT03382938 ↗ NCT01760174 ↗ NCT03691935 ↗ NCT03801265 ↗ NCT02949271 ↗ NCT02651519 ↗ NCT01760161 ↗ NCT01726205 ↗ NCT00927979 ↗ NCT02933671 ↗ NCT02053558 ↗ NCT02472522 ↗ NCT01719237 ↗ NCT02449720 ↗ NCT07624916 ↗ NCT00910013 ↗ NCT02841488 ↗ NCT02449486 ↗ NCT02164825 ↗ NCT01686347 ↗ NCT04495504 ↗ NCT05323175 ↗ NCT00586976 ↗ NCT02841982 ↗ NCT06520306 ↗ NCT01142622 ↗ NCT07316166 ↗ NCT02499575 ↗ NCT00542542 ↗ NCT04016740 ↗ NCT02125903 ↗ NCT03080142 ↗ NCT00724035 ↗ NCT00616577 ↗ NCT01556724 ↗ NCT01759940 ↗ NCT00638508 ↗ NCT02282956 ↗ NCT00616603 ↗ NCT02311517 ↗ NCT03502642 ↗ NCT02450045 ↗ NCT03444636 ↗ NCT01967524 ↗ NCT03921034 ↗ NCT05279898 ↗ NCT02450084 ↗ NCT02163980 ↗ NCT06086483 ↗ NCT00427947 ↗ NCT03663478 ↗ NCT01825863 ↗ NCT06376058 ↗ NCT02908711 ↗ NCT04910165 ↗ NCT05962970 ↗ NCT03195309 ↗ NCT01272921 ↗ NCT07386600 ↗ NCT05749367 ↗ NCT06087549 ↗ NCT00653926 ↗ NCT07591233 ↗ NCT03502889 ↗ NCT02630290 ↗ NCT06087562 ↗ NCT02893423 ↗ NCT06520150 ↗ NCT04488315 ↗ NCT02355093 ↗ NCT03329456 ↗ NCT03265223 ↗ NCT04834440 ↗ NCT05188053 ↗ NCT06677697 ↗ NCT01592630 ↗ NCT02689024 ↗ NCT05110339 ↗ NCT03768440 ↗ NCT04118777 ↗ NCT05979558 ↗ NCT04011150 ↗ NCT06519955 ↗ NCT02785276 ↗ NCT03634111 ↗ NCT00724685 ↗ NCT02091297 ↗ NCT02451605 ↗ NCT03688269 ↗ NCT01922596 ↗ NCT05124704 ↗ NCT02524652 ↗ NCT01866917 ↗ NCT04833296 ↗ NCT07007650 ↗ NCT01923623 ↗ NCT07079436 ↗ NCT06509958 ↗ NCT02946268 ↗ NCT06711679 ↗ NCT04588389 ↗ NCT05320718 ↗ NCT01593319 ↗ NCT03077919 ↗ NCT01698203 ↗ NCT03385967 ↗ NCT02006355 ↗ NCT02185924 ↗ NCT05964985 ↗ NCT02431065 ↗ NCT02589041 ↗ NCT05231941 ↗ NCT02033603 ↗ NCT03138668 ↗ NCT02945696 ↗ NCT01143025 ↗ NCT02424630 ↗ NCT02787018 ↗ NCT01094106 ↗ NCT07006168 ↗ NCT02242201 ↗ NCT05773846 ↗ NCT03618264 ↗ NCT01935596 ↗ NCT03797924 ↗ NCT05549492 ↗ NCT00956709 ↗ NCT06233630 ↗ NCT01493986 ↗ NCT02094339 ↗ NCT05446727 ↗ NCT03316378 ↗ NCT02788019 ↗ NCT07509866 ↗ NCT00769054 ↗ NCT02649179 ↗ NCT04199013 ↗ NCT03796572 ↗ NCT04198662 ↗ NCT06614010 ↗ NCT02525211 ↗ NCT02944526 ↗ NCT02276495 ↗ NCT02465827 ↗ NCT05813847 ↗ NCT04759742 ↗ NCT02701296 ↗ NCT07145775 ↗ NCT06511765 ↗ NCT02624089 ↗ NCT05054179 ↗ NCT03326609 ↗ NCT03005808 ↗ NCT06883370 ↗ NCT06288841 ↗ NCT02501863 ↗ NCT02007850 ↗ NCT03666663 ↗ NCT04005404 ↗ NCT03506620 ↗ NCT00801138 ↗ NCT05519189 ↗ NCT01964911 ↗ NCT00529425 ↗ NCT02184559 ↗ NCT03632044 ↗ NCT06045884 ↗ NCT04773301 ↗ NCT02178449 ↗ NCT01318161 ↗ NCT00883194 ↗ NCT02691195 ↗ NCT00825786 ↗ NCT05519592 ↗ NCT02502487 ↗ NCT03622047 ↗ NCT00923494 ↗ NCT02299271 ↗ NCT02691442 ↗ NCT02453516 ↗ NCT07171125 ↗ NCT06185608 ↗ NCT03435692 ↗ NCT05190120 ↗ NCT02506855 ↗ NCT02365727 ↗ NCT05122338 ↗ NCT03680716 ↗ NCT00421967 ↗ NCT05922605 ↗ NCT03023462 ↗ NCT01855529 ↗ NCT02586454 ↗ NCT04481451 ↗ NCT04761887 ↗ NCT00968955 ↗ NCT02579629 ↗ NCT07076368 ↗ NCT04400721 ↗ NCT05667324 ↗ NCT03073928 ↗ NCT03073889 ↗ NCT07259772 ↗ NCT04141319 ↗ NCT01828788 ↗ NCT01963299 ↗ NCT05843344 ↗ NCT04196270 ↗ NCT01242644 ↗ NCT00825422 ↗ NCT01782781 ↗ NCT04282239 ↗ NCT03794505 ↗ NCT02242591 ↗ NCT07327372 ↗ NCT02585011 ↗ NCT02643563 ↗ NCT04814745 ↗ NCT03142880 ↗ NCT00150865 ↗ NCT02829697 ↗ NCT02462382 ↗ NCT06048341 ↗ NCT02801799 ↗ NCT06379490 ↗ NCT03679897 ↗ NCT00567450 ↗ NCT06321354 ↗ NCT00210132 ↗ NCT03149783 ↗ NCT04824599 ↗ NCT07075783 ↗ NCT02829944 ↗ NCT03187899 ↗ NCT05642026 ↗ NCT03421821 ↗ NCT01307215 ↗ NCT02428283 ↗ NCT07180979 ↗ NCT02647047 ↗ NCT06189781 ↗ NCT05974501 ↗ NCT06048848 ↗ NCT02565303 ↗ NCT06048874 ↗ NCT05755334 ↗ NCT05286008 ↗ NCT02387021 ↗ NCT02698995 ↗ NCT01217580 ↗ NCT03781505 ↗ NCT07519109 ↗ NCT04996979 ↗ NCT06284941 ↗ NCT04292691 ↗ NCT04763434 ↗ NCT02182999 ↗ NCT00768456 ↗ NCT02460640 ↗ NCT03998813 ↗ NCT02584452 ↗ NCT04669145 ↗ NCT00672100 ↗ NCT05642416 ↗ NCT03990038 ↗ NCT03068260 ↗ NCT03011905 ↗ NCT02365181 ↗ NCT06964347 ↗ NCT02182752 ↗ NCT04130464 ↗ NCT07607535 ↗ NCT05053087 ↗ NCT00801528 ↗ NCT07607509 ↗ NCT04764045 ↗ NCT02799589 ↗ NCT06875427 ↗ NCT02278601 ↗ NCT02793947 ↗ NCT04996290 ↗ NCT06054750 ↗ NCT06801587 ↗ NCT01450007 ↗ NCT07604376 ↗ NCT06381622 ↗ NCT04138901 ↗ NCT01452126 ↗ NCT06447194 ↗ NCT02361775 ↗ NCT07603921 ↗ NCT00727935 ↗ NCT00823576 ↗ NCT04917055 ↗ NCT01276925 ↗ NCT03013361 ↗ NCT02223364 ↗ NCT03185403 ↗ NCT03428633 ↗ NCT03995563 ↗ NCT07330999 ↗ NCT00768248 ↗ NCT04665531 ↗ NCT05664542 ↗ NCT04338984 ↗ NCT05753397 ↗ NCT06470542 ↗ NCT04916691 ↗ NCT06470334 ↗ NCT04916418 ↗ NCT01547416 ↗ NCT05972018 ↗ NCT03427385 ↗ NCT00802048 ↗ NCT03069183 ↗ NCT06470204 ↗ NCT06470139 ↗ NCT02037633 ↗ NCT05543109 ↗ NCT01278264 ↗ NCT05544721 ↗ NCT02726620 ↗ NCT07174440 ↗ NCT01549704 ↗ NCT04474366 ↗ NCT03513276 ↗ NCT02279628 ↗ NCT07176065 ↗ NCT03015532 ↗ NCT01463865 ↗ NCT05753644 ↗ NCT04290442 ↗ NCT02645474 ↗ NCT02798835 ↗ NCT02527577 ↗ NCT00358280 ↗ NCT03279679 ↗ NCT06688136 ↗ NCT02181296 ↗ NCT01307969 ↗ NCT02161705 ↗ NCT05708989 ↗ NCT04769713 ↗ NCT04473508 ↗ NCT02385097 ↗ NCT02225418 ↗ NCT03628040 ↗ NCT06405724 ↗ NCT02581683 ↗ NCT04472299 ↗ NCT06406010 ↗ NCT02903719 ↗ NCT04288349 ↗ NCT03935815 ↗ NCT02225054 ↗ NCT05775861 ↗ NCT03936387 ↗ NCT02162121 ↗
Known as	GB-6002	“This study is to evaluate the safety and tolerability of single dose of GB-6002 (Ropivacaine) Local Infiltration in healthy male Adults.” NCT06095973 ↗
Known as	Nai Le Pin	“15 mL of 1% ropivacaine (Nai Le Pin 10mg/mL; by AstraZeneca AB, Sweden)” NCT07209345 ↗
Known as	Naropeine	“Ropivacaine 500mg/100ml Naropeine” NCT02080728 ↗ 3 “Naropeine (Ropivacaine)” NCT00724685 ↗ NCT05848375 ↗ NCT05969457 ↗
Known as	Naropin	“As part of abdominal surgery, local anesthetics (Naropin (Ropivacaine)) are generally administered in the end of surgery to reduce postoperative pain and promote recovery of...” NCT02819544 ↗ 16 “Naropin® (ropivacaine HCl Injection, USP) bolus + Ropivacaine 0.2% Pre-Filled Dispenser infusion - "Ropivacaine Infusion treatment arm"” NCT02959476 ↗ “Patient will receive a single shot of Ropivacaine Injection [Naropin] 0.5% 20 mL injected at the erector spinae plane” NCT03628040 ↗ “Mixed solution for nerve block, made of 0.75% ropivacaine (Naropin, Astrazeneca AB) diluted in different proportions.” NCT05205720 ↗ “4ml of 0.25% ropivacaine (prepared from Naropin, 10ml:75mg) is injected into each intercostal space.” NCT07079436 ↗ “ropivacaine (Naropin) 0.2% according to a protocol 8-10 cc per hour up to 24 hours after surgery” NCT06382285 ↗ “Ropivacaine Hydrochloride 10 MG/ML [Naropin]” NCT06006026 ↗ “Naropin” NCT05972018 ↗ NCT05831449 ↗ NCT03591146 ↗ NCT01489631 ↗ NCT04551924 ↗ NCT01759706 ↗ NCT05080959 ↗ NCT06534697 ↗ NCT03838133 ↗ NCT00512395 ↗
Known as	Naropin (ropivacaine hcl)	“Naropin (ropivacaine hcl)” NCT01556724 ↗
Known as	Naropin injection	“Active Comparator: Naropin injection(Ropivacaine hydrochloride), single dose.” NCT06095973 ↗
Known as	Naropin, 0.5% Injectable Solution	“Naropin, 0.5% Injectable Solution” NCT04551924 ↗ 1 “Naropin, 0.5% Injectable Solution” NCT03838133 ↗
Known as	NAROPINA	“DEPO-MEDROL 40 mg/ml + 1 cc di NAROPINA 0,75% 7,5 mg/ml” NCT06082271 ↗
Known as	Naropine	ClinicalTrials.gov intervention name — accepted as the source's own label NCT01317368 ↗
Known as	PRF110	“PRF-110 is a viscous, yellowish clear oily solution of ropivacaine intended for administration into surgical sites to provide post-operative analgesia.” NCT05773846 ↗ 3 “PRF110- oily solution (Ropivacaine)” NCT01681966 ↗ NCT02784327 ↗ NCT00883194 ↗
Known as	Product name: Ropivacain "Fresenius Kabi"	“Product name: Ropivacain "Fresenius Kabi"” NCT02242591 ↗
Known as	Raropin	“0.375%ropivacaine (Raropin) 25ml will be given” NCT04266236 ↗
Known as	rocaine	ClinicalTrials.gov intervention name — accepted as the source's own label NCT02331576 ↗
Known as	Ropimol	“Drug: ropivacaine Other name: Ropimol 0.5% ropivacaine (isobaric) 4.5 ml for the patients \< 160 cm tall, 5.0 ml for 161-170 cm tall, 5.5 ml for 171-180 cm tall, and 6.0 ml \> 180 cm” NCT03293472 ↗
Known as	ropivacain	“Patients will be scheduled to receive routine analgesic and an unilaterally dual TAP block with 2 points injections of 15 ml of 0,375 % Ropivacain( in total 30 ml 0,375% Ropivacain).” NCT02132065 ↗ 7 “A solution including both ropivacain and diclofenac continuously delivered to the wound is used for post-cesarean pain control” NCT01211431 ↗ “Ropivacain” NCT01025102 ↗ NCT05693454 ↗ NCT06230081 ↗ NCT07350252 ↗ NCT05648266 ↗ NCT02805582 ↗
Known as	Ropivacain Fresenius	“Ropivacain Fresenius 0.2% is a solution for infusion/ injection and will be continuously administered with an elastomer pump through the surgically placed intercostal catheter...” NCT04939545 ↗
Known as	ROPIVACAIN Sintetica	“Ropivacaine 2mg/ml (ROPIVACAIN Sintetica 2 mg/ml ™, Sintetica-Bioren, Couvet, Schweiz)” NCT02414373 ↗
Known as	Ropivacaine 0.75% :( Naropeine 7.5mg/ml, AstraZeneca)	“Ropivacaine 0.75% :( Naropeine 7.5mg/ml, AstraZeneca)” NCT01558713 ↗
Known as	Ropivacaine = Narop	“Ropivacaine = Narop” NCT01367418 ↗
Known as	RopivacaIne chlorhydrate	“Drug: RopivacaIne chlorhydrate” NCT02527577 ↗
Known as	Ropivacaine HCL	“Suprascapular nerve block under ultrasound control: injection of 5ml Ropivacaine HCL 2mg /ml” NCT02944526 ↗ 9 “local anaesthetic injection of ropivacaine HCl” NCT05813847 ↗ “Ropivacaine Hcl 0.2% Inj Bag 200Ml (PIB mode)” NCT03696095 ↗ “Naropin (Ropivacaine HCl) 0.25%; Dose: 20 cc” NCT03506620 ↗ “Ropivacaine Hcl 0.5% Injection 40 mL” NCT03405922 ↗ “Ropivacaine Hcl 0.2% Inj Vil 10Ml” NCT04062045 ↗ “Ropivacaine Hcl 0.5% Inj Vil 30Ml” NCT03502889 ↗ “Drug: Ropivacaine HCL” NCT07092566 ↗ “Drug: Ropivacaine HCL” NCT03149783 ↗ NCT02679560 ↗
Known as	Ropivacaine HCL Injection	“Ropivacaine HCL Injection” NCT06574269 ↗
Known as	ropivacaine HCl Injection, USP	“Naropin® (ropivacaine HCl Injection, USP) bolus + Ropivacaine 0.2% Pre-Filled Dispenser infusion - "Ropivacaine Infusion treatment arm"” NCT02959476 ↗
Known as	ropivacaine hydrochloride	“solution containing 200 mg of ropivacaine hydrochloride (10mg/ml Kabi Fresenius Kabi Norway AS),150 mg if the patient weight was below 65kg” NCT05248724 ↗ 17 “To determine the median effective concentration of ropivacaine hydrochloride for ultrasound-guided supraclavicular brachial plexus block.” NCT02323282 ↗ “Then 0.50% Ropivacaine hydrochloride will be injected at a dose of 0.6 ml/kg of actual weight, without exceeding 30 ml.” NCT04827030 ↗ “0.5% ropivacaine hydrochloride was injected locally around the incision before the surgical incision was closed.” NCT07353307 ↗ “0.5% ropivacaine hydrochloride RSB preoperatively and saline RSB postoperatively” PMID 29426287 ↗ Feb 2018 “Active Comparator: Naropin injection(Ropivacaine hydrochloride), single dose.” NCT06095973 ↗ “stellate-ganglion block with 0.25% ropivacaine hydrochloride” NCT02651519 ↗ “intrapleural block with ropivacaine hydrochloride injection” NCT07294755 ↗ “Ropivacaïne Hydrochloride by Erector Spinae block” NCT04827030 ↗ “Ropivacaine Hydrochloride 10 MG/ML [Naropin]” NCT06006026 ↗ “Ropivacaine Hydrochloride 7.5 MG/ML” NCT04161690 ↗ “Drug: Ropivacaine hydrochloride” NCT02576223 ↗ “Drug: ropivacaine hydrochloride” NCT07651722 ↗ “ropivacaine hydrochloride” NCT04368364 ↗ NCT05561309 ↗ NCT02438852 ↗ NCT03360214 ↗ NCT07164807 ↗
Known as	Ropivacaine Hydrochloride Injection , Naropin , AstraZeneca AB, Sweden	“Ropivacaine Hydrochloride Injection , Naropin , AstraZeneca AB, Sweden” NCT07079436 ↗
Known as	Ropivacaine Kabi	“or Ropivacaine Kabi (Ropivacaine Kabi) (Ropivacaine) Solution for injection 7.5 mg / ml” NCT03302689 ↗
Known as	Ropivacaine Monohydrochloride	“Drug: Ropivacaine Monohydrochloride” NCT02944526 ↗
Known as	Ropivacane	“To Compare Post-op Analgesic Effectiveness of Ropivicaine+Dexamethasone and Ropivacane+Dexmetomidine in TAP Block in Stoma Reversal Under GA in Terms of Duration of Analgesia.” NCT07368075 ↗
Known as	ropivicaine	“Injection Cocktail includes: 10mg Morphine, 30mg Ketorolac, 3.5ug/ml (385ug total) of Ropivicaine, 2.5ug /ml (275ug total) Epinephrine with the remainder of the solution made...” NCT01667445 ↗ 27 “To Compare Post-op Analgesic Effectiveness of Ropivicaine+Dexamethasone and Ropivacane+Dexmetomidine in TAP Block in Stoma Reversal Under GA in Terms of Duration of Analgesia.” NCT07368075 ↗ “Single Shot Pre-operative injections of 10 mL of 0.25% Ropivicaine for the Pecs 1 injection, and 20 mL of 0.25% Ropivacaine for the Pecs 2 injection” NCT03201809 ↗ “The corticosteroid is prepared in a 10 ml syringe by combining 1-2 mL Kenalog \[40 mg/dL\], 6-8 mL sterile normal saline, 3-4 mL Ropivicaine 1%.” NCT05288725 ↗ “Ropivicaine 0.5% 25 mL will be used during the procedure for initiation of pain control.” NCT03540095 ↗ “Subject will receive an interscalene block with Ropivicaine 0.5% (20cc)” NCT04364867 ↗ “0.1% ropivicaine + 10 mcg/mL hydromorphone at 6 mL/hr continuous rate” NCT02423876 ↗ “using 25 ml of 0.5% Ropivicaine plus saline injection postoperative” NCT03253198 ↗ “0.5% Ropivicaine, 24.6 mL” NCT03696199 ↗ NCT02970097 ↗ NCT03349034 ↗ NCT01816477 ↗ NCT02744352 ↗ NCT00620828 ↗ NCT01680692 ↗ NCT02721017 ↗ NCT05488847 ↗ NCT02474654 ↗ NCT02497911 ↗ NCT05355597 ↗ NCT04413799 ↗ NCT00945620 ↗ NCT02297191 ↗ NCT03151434 ↗ NCT02838329 ↗ NCT01759407 ↗ NCT00923598 ↗ NCT02730728 ↗
Known as	ropivicaine 0.2%	ClinicalTrials.gov intervention name — accepted as the source's own label NCT04080739 ↗
Known as	Rupivacane	“The needle entry point will be anesthetized with 20 mL 0.25% Rupivacane plus dexamethasone 4 mg.” NCT07368075 ↗
Known as	Thoracic paravertebral block	ClinicalTrials.gov intervention name — accepted as the source's own label NCT04482192 ↗
Action	Inhibit	“It produces effects similar to other local anaesthetics via reversible inhibition of sodium ion influx in nerve fibres.” PMID 21712863 ↗ Mar 2011
Modality	Other / unclassified	“Local anaesthetic wound infiltration” PMID 21484739 ↗ Apr 2011
Route	Other	“perineural ropivacaine” PMID 18362603 ↗ Apr 2008